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VIOXX AND CONSUMER PRODUCT PAIN
RELIEF: THE POLICY IMPLICATIONS OF
LIMITING COURTS' REGULATORY
INFLUENCE OVER MASS CONSUMER
PRODUCT CLAIMS
Alec Johnson*
I. SOMEONE MUST HAVE CHECKED
THIS OUT, RIGHT?
First, your prescription pain reliever gives you a heart attack.'
Next, your efforts to eat healthier land you a case of salmonella.'
Then, your dog's gravy-covered kibble attacks her kidneys.3 Finally,
as if to make sure that no one in the American household goes
unscathed, your kid gets lead poisoning from playing with Barbie.4
It is likely of little comfort that you are in good company.
Combined, the recent recalls of Vioxx, bagged spinach, pet food, and
* J.D. Candidate, May 2009, Loyola Law School, Los Angeles; B.A., Pomona College. I
would like to thank the editors and staff of the Loyola of Los Angeles Law Review for their hard
work in preparing this Article for production. Special thanks to Professor Georgene Vairo and
Associate Dean Bill Araiza for their insights and suggestions on this topic, as well to my brother
Foster for his timely encouragement. Most importantly, I must thank the best sugar mama a law
student could ever have, my beautiful wife Shanna.
1. See Gardiner Harris, F.D.A. Official Admits 'Lapses' on Vioxx, N.Y. TIMES, Mar. 2,
2005, at A15 (stating that FDA officials estimate that as many as 55,000 patients who had been
prescribed Vioxx as a pain reliever may have died as a result of heart attacks or strokes induced
by the drug).
2. See Spinach Recalled After Positive Test for Salmonella, N.Y. TIMES, Aug. 30, 2007, at
A19 (noting that prior contamination of spinach with E. coli had killed 3 people and sickened
200).
3. See Katie Zezima, 22 Brands of Dog Biscuits Are Added to Pet Food Recall, N.Y.
TIMES, Apr. 6, 2007, at A15 (reporting that the FDA has received more than 12,000 complaints
associated with a recall of pet food containing contaminated wheat gluten).
4. See Eric Lipton, More Lead-Tainted Items are Found at Retailers, N.Y. TIMES, Sept. 19,
2007, at C2 (reporting that some Barbie related items were found to be coated with paint with
lead concentrations significantly higher than the legal limit).
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lead-painted toys sent U.S. consumers scrambling through toy boxes
and cabinets to weed out heretofore unknown dangers.
In so doing, U.S. consumers have begun to question some basic
assumptions about the safety of items filling American households.'
As the mother of one child sickened from contaminated spinach
testified before Congress, "You live in the United States of America
and this isn't supposed to happen. There is an assumption that
everything is going to be O.K., that someone must have checked this
out, but it is not the case."6 The political effects that come with a
consumer-based economy suddenly mistrusting the products that
define it cannot be underestimated. Over the past year, Congress has
held multiple hearings investigating both the Food and Drug
Administration ("FDA")7  and the Consumer Product Safety
Commission ("C.P.S.C."),t as calls have come to revamp regulatory
policy in response to the wave of recalls.9
Yet Congress is not the sole point of impact for this pressure to
protect consumers. When regulatory safeguards fail, courts are often
the initial branch to confront the dangers that have reached large
classes of consumers. From asbestos in their homes" to dangerous
defects in their cars," U.S. consumers have primarily relied upon the
courts, rather than regulatory agencies, to provide relief and future
protection. Compared with other industrialized nations, regulatory
safeguards in the U.S. have been traditionally limited due to
5. See Eric Lipton & Louise Story, Toy Makers Seek Standards for U.S. Safety, N.Y.
TIMES, Sept. 7, 2007, at C1 ("'These news stories have really shaken the confidence of American
families in toys."' (quoting Sen. Richard J. Durbin)).
6. Marian Burros, Who's Watching What We Eat?, N.Y. TIMES, May 16, 2007, at F1
(internal quotation marks omitted).
7. See Alexei Barrionuevo, Food Imports Often Escape Scrutiny, N.Y. TIMES, May 1,
2007, at C1 (reporting on hearing involving the FDA's handling of food safety issues); Gardiner
Harris, F.D.A. Remains Unsettled in Wake of New Questions, N.Y. TIMES, May 31, 2007, at A14
(reporting on hearing involving the FDA's handling of drug safety issues).
8. See Eric Lipton, Senators Urge More Stringent Rules for Toy Safety, N.Y. TIMES, Sept.
13, 2007, at C1 (discussing Senate proposals to revamp the C.P.S.C.).
9. See, e.g., Stephen Labaton, Bush to Offer Safety Plan on Imports, N.Y. TIMES, Nov. 6,
2007, at Cl.
10. See In re Asbestos Litig., 90 F.3d 963 (5th Cir. 1996) (certifying mandatory class in
Texas asbestos litigation), vacated sub nom. Flanagan v. Ahern, 521 U.S. 1114 (1997) (vacating
the judgment and remanding the case to the Fifth Circuit for further consideration in light of
Amchem Products., Inc. v. Windsor, 521 U.S. 591 (1997)).
11. See White v. Gen. Motors Corp., 97-1028, p. 8-9 (La. App. 1 Cir. 6/29/98), 718 So. 2d
480 (certifying a class action settlement involving pickup truck owners injured as a result of
defective fuel tanks).
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longstanding concerns about over-regulation limiting economic
growth. 2  The result is a tacit reliance upon U.S. courts to fill the
void where consumer interests have not been adequately protected.'3
As such, the safety of U.S. consumer products is balanced between
low regulatory safeguards and the economic pressures of potential
litigation. But what some consumers, like the mother mentioned
earlier, are beginning to question is whether the current balance of
regulation and litigation adequately protects consumer interests.
The circumstances surrounding the recall of Vioxx outline the
general parameters of this question. Years before even warning
labels were added to Vioxx, the drug's manufacturer, Merck & Co.,
was aware of a potential increased risk of heart attack and stroke
associated with the drug. 4 While the FDA subsequently became
quite concerned about these risks, the agency lacks the authority to
demand specific warning labels for drugs. 5 Forced to negotiate with
Merck over the language and size of warning labels for Vioxx, FDA
officials struggled to find an acceptable compromise as the drug
remained on the market with no warnings. 6 Indeed, Vioxx had been
Merck's cornerstone product since its introduction in 1999,
accounting for $2.5 billion in sales in 2003 and representing 11
percent of the company's revenue. 7 Fearing the loss of millions of
dollars in sales if the warnings were too prominent, Merck resisted
FDA attempts to make the warnings more visible, 8 despite the
company's knowledge of the drug's potential dangers. 9
12. See Stephen B. Burbank, Jurisdictional Conflict and Jurisdictional Equilibration: Paths
to a Via Media?, 26 HOuS. J. INT'L L. 385, 387 (2004) (discussing how the United States, unlike
many other developed nations, offers few administrative remedies to harmed consumers and
subsequently uses courts to fill the gap).
13. See id.
14. See John Curran, Vioxx Troubled Merck Scientist, RECORD (Bergen County, NJ), Sept.
22, 2005, at B3; Harris, supra note 1.
15. See Harris, supra note 1 (describing how the FDA must negotiate with pharmaceutical
companies over the warning labels placed on medications).
16. See Curran, supra note 14 (noting internal Merck e-mails where the company's chief
scientist called FDA officials "bastards" for suggesting a warning label that the Vioxx
development team thought was "ugly").
17. See Gina Kolata, A Widely Used Arthritis Drug Is Withdrawn, N.Y. TIMES, Oct. 1, 2004,
at Al.
18. See Curran, supra note 14; Harris, supra note 1.
19. See Alex Berenson et al., Dangerous Data - Retracing a Medical Trial, N.Y. TIMES,
Nov. 14, 2004, at N I (detailing Merck's knowledge of potential heart risks associated with Vioxx
years before warnings were added or the drug was recalled).
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After almost five years on the market, additional studies
revealed a clear link between Vioxx and increased rates of heart
attack and stroke.2 ° Merck subsequently pulled the drug in late
2004.21 With more than twenty million Americans having taken
Vioxx between 1999 and 2004, epidemiologists estimate that Vioxx
may have caused over 100,000 heart attacks.2 Federal and state
courts across the country were quickly flooded with over 25,000
suits against Merck,23 including multiple class actions,24 which all
generally cited Merck's failure to properly warn patients of Vioxx's
risks.25
Despite initial plaintiff victories that plunged the company's
stock price,26 Merck maintained a strategy of litigating each case
separately 27 and defeated attempts to certify nationwide class
actions.28  Through twenty trials over the past two years, Merck
managed to reverse its fortunes by securing defense verdicts or hung
juries in fifteen of the cases.2 9  These results led to a tentative
settlement that could resolve a vast majority of the pending cases and
cap Merck's liability at $4.85 billion.30 While amounting to nine
20. See Kolata, supra note 17 (.'[T]here was a discernible and unexpected increase in
cardiovascular disease rates .... What we saw was stunning."' (quoting Dr. Peter S. Kim,
President of Merck Research Labs)).
21. See id.
22. See Alex Berenson, Vioxx Jury Adds More in Damages, N.Y. TIMES, Apr. 12, 2006, at
Cl.
23. See Sarah Kershaw, New York and City Sue Merck over Vioxx, N.Y. TIMES, Sept. 18,
2007, at B3.
24. See, e.g., In re Vioxx Prods. Liab. Litig., 239 F.R.D. 450 (E.D. La. 2006); Int'l Union of
Operating Eng'rs Local No. 68 Welfare Fund v. Merck & Co., 192 N.J. 372 (2007).
25. See Bill Dawson & Alex Berenson, The Vioxx Decision: The Jury; Working Through a
Decision Cut in Shades of Deep Gray, N.Y. TIMES, Aug. 20, 2005, at C 13 (reporting on Texas
juror's view of the inadequacy of the warning labels originally applied to Vioxx).
26. See Alex Berenson, Jury Calls Merck Liable in Death of Man on Vioxx, N.Y. TIMES,
Aug. 20, 2005, at A l [hereinafter Berenson, Merck Liable].
27. See Alex Berenson, Analysts See Merck Victory in Vioxx Deal, N.Y. TIMES, Nov. 10,
2007, at Al [hereinafter Berenson, Analysts].
28. See In re Vioxx Prods. Liab. Litig., 239 F.R.D. 450 (denying certification to a nationwide
class of plaintiffs claiming personal injury as a result of taking Vioxx); Int 'l Union of Operating
Eng'rs Local No. 68 Welfare Fund, 192 N.J. 372 (denying certification to a nationwide class of
third-party payors who helped pay for Vioxx prescriptions as part of health insurance benefits).
29. See Andrew Longstreth, $4.85 Billion Vioxx Settlement Validates Merck's Courthouse
Strategy, AM. LAW., Nov. 12, 2007.
30. See Alex Berenson, Merck Agrees to Settle Vioxx Suits for $4.85 Billion, N.Y. TIMES,
Nov. 9, 2007, at Al [hereinafter Berenson, Settlement] (noting that the settlement only becomes
effective if 85 percent of plaintiffs agree to accept the offer, and then it would provide plaintiffs
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months of the company's profit, the settlement is still seen as a
relative victory for Merck, since analysts earlier estimated that a
potential settlement could have cost as much as $25 billion and
plunged the company into bankruptcy.3'
Yet, the course of the Vioxx litigation and the current proposed
settlement show how recent trends in complex litigation have
substantially impacted consumer interests. In denying class
certification of a nationwide class of injured plaintiffs and scheduling
only a limited number of initial trials,32 U.S. District Court Judge
Eldon E. Fallon of the Eastern District of Louisiana allowed Merck
to pursue its strategy of litigating claims separately. Merck was thus
able to attack the facts specific to individual plaintiffs regarding
causation.33 Yet after the initial wave of trials, Judge Fallon
evidently pressured the parties to reach a settlement,34 possibly by
threatening to substantially increase the pace of the pending trials.
35
"'He had everything to do with it,"' said one attorney involved in the
negotiations.36  With the leverage that comes with managing
thousands of coordinated cases, the decisions of courts in handling
such complex litigation matters have far-reaching effects that
ultimately act as de facto regulation upon the industry in question
and affect the interests of future consumers.37
While Merck's anticipated level of liability has been continually
evaluated and reflected in its stock price,38 the market effects of the
with varying amounts of compensation based on the severity of their injuries and their respective
length of time taking Vioxx).
3 1. See Berenson, Analysts, supra note 27.
32. See In re Vioxx Prods. Liab. Litig., 239 F.R.D. 450.
33. See Alex Berenson, Legal Stance May Pay Offfor Merck, N.Y. TIMES, Aug. 4, 2006, at
C1 [hereinafter Berenson, Legal Stance] (noting that the plaintiffs in the Vioxx cases were
generally older with additional risk factors for heart attack, which complicated causation issues).
34. See Berenson, Settlement, supra note 30.
35. See Joe Nocera, Forget Fair; It's Litigation as Usual, N.Y. TIMES, Nov. 17, 2007, at CI
("If Merck had continued to fight, the judges could have piled on so many trials that the company
would have been begging for mercy.").
36. Berenson, Settlement, supra note 30.
37. See Victor E. Schwartz & Leah Lorber, State Farm v. Avery: State Court Regulation
Through Litigation Has Gone Too Far, 33 CONN. L. REV. 1215, 1215-18 (2001) (discussing the
use of state courts to regulate specific industry issues); see also Richard A. Nagareda, The
Preexistence Principle and the Structure of the Class Action, 103 COLUM. L. REV. 149, 192-98
(2003) (arguing that regulation through litigation undermines democratic principles).
38. See, e.g., Judge Denies Class Status for Lawsuits over Vioxx, N.Y. TIMES, Nov. 23,
2006, at C2 (reporting that shares of Merck rose 16 cents following the district court's decision to
deny nationwide class certification to plaintiffs claiming injury from Vioxx); Berenson, Legal
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Vioxx cases will eventually reach beyond the financial markets. Just
as Merck's financially motivated decision to fight the FDA on
warning labels inevitably impacted consumers,39 so too will the
outcome of the Vioxx litigation affect the risk calculus applied by
other drug manufacturers in evaluating future products. Indeed, the
success of Merck's aggressive litigation strategy may establish a new
standard and new expectations for the defense of mass consumer
product claims.4" As a result, consumer warning standards for the
industry as a whole will be influenced as much by the market effects
of the Vioxx cases as they are by the FDA.
But is this tort-based regulatory influence an appropriate role for
courts? Does the settlement of a class of individual claims actually
reflect a solution to the problem underlying those claims? As the
size of aggregated claims has increased with the development of
class actions and other complex litigation procedures,4 courts have
struggled with the burden of serving more as regulator than
adjudicator.42 In dealing with large classes of claims, courts have at
times even suggested legislative intervention over judicial
administration.43 Particularly within the realm of class certification
under Federal Rule of Civil Procedure 23 ("Rule 23"), these issues
have greatly influenced the changing landscape of complex litigation
in recent years.
Created in the progressive era of Brown v. Board of Education,44
the modem class action was intended to allow plaintiffs to seek relief
Stance, supra note 33 (noting a 27 percent increase in Merck's stock price following several
favorable jury decisions regarding Vioxx claims).
39. See Harris, supra note 1; Berenson et al., supra note 19.
40. See Berenson, Analysts, supra note 27 ("More broadly, the case shows that after years of
aggressively lobbying against trial lawyers, corporate America has regained substantial leverage
against plaintiffs and their lawyers - whose lawsuits bankrupted Dow Coming and the asbestos
industry in the 1990s. In many states, changes governing lawsuits have made claims tougher to
bring and win, while much public opinion has turned against plaintiffs.").
41. See John C. Coffee, Jr., Class Wars: The Dilemma of the Mass Tort Class Action, 95
COLUM. L. REV. 1343, 1356 (1995) (noting the increase in mass tort actions during the 1980s).
42. See Alexandra D. Lahav, The Law and Large Numbers: Preserving Adjudication in
Complex Litigation, 59 FLA. L. REv. 383, 410-16 (2007) (discussing the administrative
difficulties faced by the district court in administering the settlement of claims related to diet drug
litigation).
43. See Amchem Prods., Inc. v. Windsor, 521 U.S. 591, 597-98 (1997) (discussing a report
by the Ad Hoc Committee on Asbestos Litigation appointed by Chief Justice Rehnquist stating
that the wave of national asbestos litigation "required federal legislation creating a national
asbestos dispute-resolution scheme").
44. 347 U.S. 483 (1954).
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through aggregation for harms that could not be realistically
redressed through individual litigation.45 As described by Chief
Justice William Burger in Deposit Guaranty National Bank v.
Roper,46 the class action mechanism is "an evolutionary response to
the existence of injuries unremedied by the regulatory action of
government."47  Yet the power of class actions to "deputiz[e] all
attorneys everywhere to enforce our laws"48 has always brought with
it concerns over procedural fairness. Indeed, just after his comment
on the development of class actions, Chief Justice Burger noted that
the "potential for misuse of the class-action mechanism is obvious.
Its benefits to class members are often nominal and symbolic, with
persons other than class members becoming the chief
beneficiaries."49
In trying to balance these concerns, Congress, the courts, and
practitioners have engaged in an ongoing struggle over the scope and
application of class actions.5" As noted over twenty-five years ago in
Deposit Guaranty, "[T]he remedy for abuses does not lie in denying
the relief sought . . . , but with re-examination of Rule 23 as to
untoward consequences."'" The results of this ongoing examination
have continually altered the litigation of mass consumer product
actions both for high-value claims (such as the heart attack victims
45. See Amchem, 521 U.S. at 617 ("'The policy at the very core of the class action
mechanism is to overcome the problem that small recoveries do not provide the incentive for any
individual to bring a solo action prosecuting his or her rights."' (quoting Mace v. Van Ru Credit
Group., 109 F.3d 338, 344 (1997))); see also Deborah R. Hensler, Revisiting the Monster: New
Myths and Realities of Class Action and Other Large Scale Litigation, II DUKE J. COMP. & INT'L
L. 179, 179-80 (2001) (discussing differing opinions over the intent of the 1966 changes to Rule
23).
46. 445 U.S. 326 (1980).
47. Id. at 339.
48. Statement of William T. Coleman, Jr. (Nov. 22, 1996), in 4 COMM. ON RULES OF
PRACTICE AND PROCEDURE, JUDICIAL CONFERENCE OF THE U.S., WORKING PAPERS OF THE
ADVISORY COMMITTEE ON CIVIL RULES, PROPOSED AMENDMENTS TO RULE 23, at 449, 456
(1997).
49. Deposit Guar., 445 U.S. at 339. It should be noted, however, that this last issue extends
to all mass claims, not just those certified under a class action. The proposed Vioxx settlement,
for instance, would generally award individual plaintiffs less than $80,000 each after attorneys'
fees and require them to first go through a number of evaluations, while a limited number of
plaintiffs firms will earn nearly S2 billion in fees. See Berenson, Settlement, supra note 30.
50. See Georgene M. Vairo, Foreword: Developments in the Law: The Class Action
Fairness Act of 2005, 39 LOY. L.A. L. REV. 979 (2006).
51. 445 U.S. at339.
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involved in the Vioxx cases) and negative-value claims52 (such as the
plaintiffs in Deposit Guaranty seeking recovery for nominal credit
card service charges). 3 But recent developments in complex
litigation have largely weakened the ability of courts to protect
consumer interests, just as those interests are coming under attack
from a wave of dangerous products.
This Article will address the policy implications of recent trends
in the ongoing re-examination of Rule 23 that have substantially
impacted the regulatory influence of courts handling mass consumer
product claims. Part II will first discuss the regulatory issues
inherent to consumer product class actions, as well as the federalism
tensions that accompany them. Part III will then analyze the
Supreme Court's unwillingness to expand the federal courts'
regulatory role in handling such claims and subsequent decisions
limiting the certification of nationwide class actions. Further, this
section will examine how the Court's reluctance to clearly delineate
the boundaries of state versus federal control over nationwide class
actions exacerbated the federalism tensions already inherent to class
actions, fueling controversial forum shopping. Part IV will then
discuss how Congress's action to resolve this controversy through
the Class Action Fairness Act of 2005 ("CAFA")54 seriously limited
the viability of consumer product class actions. In so doing,
Congress correctly identified many problems with judicial
management of consumer product claims but largely ignored the
larger purpose behind such actions.
Finally, Part V will return to the current state of mass consumer
product litigation by examining the proposed Vioxx settlement.
Additionally, this section will briefly discuss the current, limited
ability of regulatory agencies to adequately manage consumer safety
issues. When seen in the context of the balance of consumer
52. Negative-value claims are generally defined as controversies in which the transactional
costs involved with pursuing the claim outweigh the potential recovery of an individual plaintiff.
See Samuel Issacharoff, Settled Expectations in a World of Unsettled Law: Choice of Law After
the Class Action Fairness Act, 106 COLUM. L. REv. 1839, 1861 (2006).
53. 445 U.S. at 327-29.
54. Class Action Fairness Act of 2005, Pub. L. 109-2, 119 Stat. 4 (2005) (codified as
amended in scattered sections of 28 U.S.C.). As will be discussed in Part D, CAFA granted
federal courts jurisdiction over class actions where only minimal diversity between the parties
was established and also placed significant restrictions upon the use of "coupon settlements"
frequently used in actions involving negative-value claims.
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protection provided by regulatory action and consumer litigation,
decisions by the Supreme Court and Congress have significantly
limited the ability of courts to act as a regulatory backstop on
consumer product issues. While these decisions were largely a
reasonable reaction to the inherent problems of using courts as a
regulatory branch, ultimate consumer interests have not been well
served. Accordingly, this Article will argue that Congress will have
to expand the regulatory authority and capability of agencies such as
the FDA and C.P.S.C. in order to adequately balance the level of
protection demanded by U.S. consumers.
II. THE REGULATORY ISSUES INHERENT TO
CONSUMER CLASS ACTIONS
During the period of the mid-1980s through the early 1990s,
federal courts were faced with a series of mass consumer product
controversies-involving asbestos,"5 Agent Orange, 6 the Dalkon
Shield," and breast implants,58 among others-that overloaded court
dockets and created an urgent need for a more efficient method to
manage such mass claims. 9 In the face of the efficiency problems
created by the sheer number of these individual cases,6° federal
courts began to expand the scope of the class action mechanism in
this period, largely because of the increases in group settlements that
accompanied class certification.6 However, many of these cases
highlighted the regulatory tensions inherent to the use of class
actions in consumer product controversies. In particular, In re
55. See In re Asbestos Litig., 90 F.3d 963 (5th Cir. 1996) (certifying mandatory class in
Texas asbestos litigation), vacated sub nom. Flanagan v. Ahem, 521 U.S. 1114, 1114-15 (1997)
(vacating the judgment and remanding the case to the Fifth Circuit for further consideration in
light of Amchem Products., Inc. v. Windsor, 521 U.S. 591 (1997)).
56. See In re "Agent Orange" Prod. Liab. Litig., 818 F.2d 145 (2d Cir. 1987).
57. See In re A.H. Robins Co., Inc., 880 F.2d 709 (4th Cir. 1989).
58. See In re Silicone Gel Breast Implants Prods. Liab. Litig., 887 F. Supp. 1469 (N.D. Ala.
1995).
59. See generally Georgene Vairo, Judicial v. Congressional Federalism: The Implications
of the New Federalism Decisions on Mass Tort Cases and Other Complex Litigation, 33 LOY.
L.A. L. REv. 1559, 1570-73 (2000) [hereinafter Vairo, Judicial v. Congressional] (noting
efficiency considerations motivating class action in mass torts).
60. See, e.g., In re "Agent Orange" Prod. Liab. Litig., 597 F. Supp. 740, 749-50 (E.D.N.Y.
1984) ("Some 600 separate cases have been sent to this district from all over the country with an
estimated fifteen thousand named plaintiffs.")
61. See Vairo, Judicial v. Congressional, supra note 59, at 1573-74.
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Rhone-Poulenc Rorer, Inc.62 (involving a class of hemophiliacs
infected with the AIDS virus through blood transfusions) laid out
many of the issues that would drive the analysis of class certification
standards over the next ten years, ultimately affecting the
management of controversies like the Vioxx litigation today.
While the AIDS virus was first identified in 1981, it was not
until 1984 that transmission of the virus through blood was
confirmed.63 Further, it was another year before the major drug
companies that manufactured blood solids had adequate procedures
in place to ensure that the products regularly relied upon by
hemophiliacs were not infected with the virus.64 During this period
in the early 1980s, it is estimated that more than 10,000 hemophiliacs
in the United States contracted the AIDS virus through infected
blood solids, resulting in roughly 2000 deaths by 1995.65 Yet with
the statute of limitations having almost expired in many states by that
time,66 these drug companies faced just 300 or so individual suits
from affected hemophiliacs, involving fewer than 500 plaintiffs.67
In fact, plaintiffs faced an uphill battle in these suits because so
little had been known about the AIDS virus during the time when
most hemophiliacs were infected.68 As such, plaintiffs were largely
relying upon an unusual "serendipity" theory based on potential
prevention measures the drug companies could have used to prevent
other known dangers at the time.69 While resisting certification of a
class of affected hemophiliacs, the defendant drug companies had in
fact won twelve of the first thirteen individual suits brought.7"
From the initial facts of Rhone-Poulenc, the challenge
confronting courts in balancing the diverse range of policy issues
inherent to Rule 23 starts to become clear.71  The plaintiffs
62. 51 F.3d 1293 (7th Cir. 1995).
63. See id. at 1294-96.
64. Id.
65. Id. at 1296.
66. Id. at 1298.
67. Id. at 1296.
68. Id.
69. Id. Plaintiffs argued that if the drug companies had used more effective measures to
screen donors for Hepatitis B, contamination by the AIDS virus would have been significantly
minimized.
70. Id.
71. Id.
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potentially affected by class certification in this case presented a
wide range of interests: from the families of deceased patients, to
those patient-claimants already ill, to those who were infected with
HIV but not yet ill, and finally the potential future claimants who
might not have known of their infection. Further, the defendant drug
companies, those parties who had invested in the industry, and even
the court system itself each had their own particular interests in the
management of the case as well.
In essence, class certification judgments require a balancing of
all of these interests, as well as policy determinations about their
relative weights. In doing so, courts are forced out of the limited,
traditional role of adjudicating specific claims and forced to act as
regulatory bodies evaluating potential costs and benefits to a broad
range of diverse interests.72  This broad judicial role creates
federalism tensions between state and federal courts, as well as
between individual states.
A. The Policy Issues Behind Rule 23 's Requirements
Initially, Rule 23(a) establishes four threshold elements required
for all federal class actions:73
(1) numerosity (a "class [so large] that joinder of all members is
impracticable");
(2) commonality ("questions of law or fact common to the
class");
(3) typicality (named parties' claims or defenses "are typical...
of the class"); and
72. See generally Judith Resnik, Constricting Remedies: The Rehnquist Judiciary, Congress,
and Federal Power, 78 IND. L.J. 223 (2003) (examining efforts to limit the ability of courts to
craft non-traditional remedies to modem controversies); see also E. Donald Elliott, Managerial
Judging and the Evolution of Procedure, 53 U. CHI. L. REV. 306 (1986) (describing the
development of "managerial judging" as an ad hoc effort by courts to manage the scope of
modem litigation).
73. As will be discussed later in this Part, the technical requirements of Rule 23-if not the
interpretation of them-are largely mirrored in most state court rules. See James M. Underwood,
Rationality, Multiplicity & Legitimacy: Federalization of the Interstate Class Action, 46 S. TEX.
L. REV. 391, 445 (2004). For a discussion of class certification requirements in individual states,
including California, New York, Illinois, Texas, and Florida, see William R. Shafton,
Developments, California 's Uncommon Common Law Class Action Litigation, 41 LOY. L.A. L.
REV. 783 (2008) and Adam Feit, Developments, Tort Reform, One State at a Time: Recent
Developments in Class Actions and Complex Litigation in New York, Illinois, Texas, and Florida,
41 LOY. L.A. L. REV. 899 (2008).
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(4) adequacy of representation (representatives "will fairly and
adequately protect the interests of the class").74
Rule 23(b) establishes additional requirements for specific types
of class actions, and it is under 23(b)(3)--designed for damages class
actions meant to be binding on all class members who do not
affirmatively opt-out 75-where two additional requirements for
maintaining most consumer products class actions are found:
(5) "Common questions must 'predominate over any questions
affecting only individual members;"'"76 and
(6) "[C]lass resolution must be 'superior to other available
methods for the fair and efficient adjudication of the controversy.
' ' 77
In establishing these six broad requirements for class
certification, the 1966 Advisory Committee that modernized Rule 23
was attempting to craft a class action mechanism that would
effectively balance multiple policy issues including judicial
economy, individual rights, uniformity of decisions, and procedural
fairness.78 Further, federal courts are also required to weigh these
same requirements before approving the settlement of a 23(b)(3)
class action, regardless of whether the class has been certified.79
Feeding into this balance of policy considerations are conflicts over
the factual cohesiveness of a class, the law applying to the class, and
the rights of individual class members. The initial requirements
under 23(a) tend to merge with each other in assessing these
74. Amchem Prods., Inc. v. Windsor, 521 U.S. 591, 613 (1997) (quoting FED. R. Civ. P.
23(a)).
75. Rules 23(b)(1) and 23(b)(2) relate to circumstances in which class members
affirmatively elect to be included in the class. See FED. R. CIv. P. 23(b)(1), 23(b)(2).
76. Amchem, 521 U.S. at 615-16 (quoting FED. R. Civ. P. 23(b)(3)). FED. R. CIv. P.
23(b)(3) provides that:
[Flactors pertinent to a court's "closer look" at the predominance and superiority
criteria [include]: "(A) the interest of members of the class in individually controlling
the prosecution or defense of separate actions; (B) the extent and nature of any
litigation concerning the controversy already commenced by or against members of the
class; (C) the desirability or undesirability of concentrating the litigation of the claims
in the particular forum; (D) the difficulties likely to be encountered in the management
of a class action."
77. Amchem, 521 U.S. at 615-16 (quoting FED. R. Civ. P. 23(b)(3)).
78. Id. at 613-18.
79. See FED. R. CIV. P. 23(e) (requiring a court to make a finding that a proposed resolution
to a class action is "fair, reasonable, and adequate" before approving a proposed "settlement,
voluntary dismissal, or compromise" that would bind class members); see also Anmchem, 521 U.S.
at 619-22 (requiring a court to find that a settlement class could be certified under the 23(a) and
23(b)(3) factors, except for 23(b)(3)(D)).
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conflicts.80 But in heightening these same policy concerns, the
predominance and superiority requirements of 23(b)(3) have led
courts to evaluate additional conflicts regarding settlement pressures
inherent in class actions and the overall procedural fairness of
allowing class certification for certain claims.
1. Cohesiveness of Class Claims
The uniformity of the "questions of law or fact"81 that potentially
connect a class is the initial focus of Rule 23(a)'s requirements.
8 2
Accordingly, courts have primarily centered their analysis on the
variation of underlying characteristics implicit to the class claims.83
The first step of this commonality/typicality analysis generally
focuses on the factual connections that might substantially
differentiate class members' claims. For instance, Judge Posner of
the Seventh Circuit noted in Rhone-Poulenc that the "differences in
the date of infection" among the potential class members was by
itself enough of a fact variation to make standard class certification
infeasible.84 However, variations in the degrees of harm or exposure
suffered by class members require courts to estimate an appropriate
point of factual commonality that arguably could be established at
multiple points.85 In so doing, courts are essentially creating
regulatory boundaries which establish how similar products or
injuries must be with each other in order for the classification to be
sustainable.86
80. Id. at 626 n.20.
81. FED. R. CIV. P.23(a).
82. See Amchem, 521 U.S. at 626 n.20 (stating that the criteria of 23(a) attempts to determine
whether the class members' claims are sufficiently interrelated). Somewhat distanced from
23(a)'s last three requirements is the numerosity requirement's indistinct burden "that joinder of
all members is impracticable." See FED. R. CIV. P. 23(a)(1). This first requirement is rarely
given significant analysis by courts, as speculative assertions of "substantial" class members has
been held to be sufficient. See, e.g., Lowdermilk v. U.S. Bank Nat'l Ass'n, 479 F.3d 994, 997
(9th Cir. 2007); Daffin v. Ford Motor Co., 458 F.3d 549, 552 (6th Cir. 2006).
83. See, e.g., In re Vioxx Prods. Liab. Litig., 239 F.R.D. 450, 460 (E.D. La. 2006) (citing In
re Baycol Prods. Litig., 218 F.R.D. 197, 205-06 (D. Minn. 2003)).
84. 51 F.3d 1293, 1296-97 (7th Cir. 1995).
85. See Amchem, 521 U.S. at 623-24 (criticizing the district court's reliance on exposure to
asbestos as a sufficient point of commonality when there were significant variations in the
degrees of exposure, source of exposure, and subsequent harm).
86. See Daffin, 458 F.3d at 552 (examining case history as to level of commonality required
between products).
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While these boundaries are generally given a "low threshold"
under the commonality requirement,87 courts have required a much
higher burden on these same factors to meet the typicality
requirement. Where an analysis of commonality tends to stop at
issues of general causation, for instance, typicality requires that a
class representative share the same "essential characteristics" as all
of the proposed class members, including course of conduct and
legal theories.88 In consumer product cases, variations in consumers'
contact with the product inevitably force courts to consider whether
these variations can allow for any claim to be "typical" of the entire
class. Naturally, variations in usage that are common to almost any
consumer product present the same questions regarding the scope of
any class. This issue is illustrated by the fact that one district court
that denied certification of a class of Vioxx users simply pasted
"Vioxx" into the typicality portion of an opinion from another
district court that had rejected class certification related to another
medication:
[T]he underlying facts and circumstances of this case do not
make the proposed personal injury class amenable to class
certification. This case involves a vast number of persons
who took different dosages of [Vioxx], at different times,
and possibly took [Vioxx] concomitantly with other
prescription drugs. Because the theories asserted by this
putative class are based on what [Merck] knew at the time
[Vioxx] was prescribed, and whether [Merck] acted
reasonably based on such knowledge, the claims of the
named representatives are not typical of the class.89
Indeed, Judge Posner could have used almost the same wording
to demonstrate variations within the potential class of hemophiliacs
from Rhone-Poulenc. Within this analysis, however, lies the
question of just what variations in usage are actually significant
enough to appropriately divide a potential class. As such, it is
important to recognize that courts are making essentially regulatory
87. In re Vioxx Prods. Liab. Litig., 239 F.R.D. at 459 ("There is a low threshold for
commonality, and the fact that some plaintiffs have different claims or require individualized
analysis does not defeat commonality.").
88. Id. at 459-60.
89. Id. at 460 (quoting In re Baycol Prods. Litig., 218 F.R.D. 197, 205-206 (D. Minn. 2003)
(alterations in original).
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decisions within this analysis that establish the potential scope of
combined claims.
Further, the broader problem borne out by the final outcome of
Rhone-Poulenc was that despite the variations among plaintiffs that
barred class certification, the court subsequently accepted a global
class settlement granting a set recovery amount per claimant.9" Judge
Posner went so far as to describe the agreement as "downright
weird" in light of the differing degrees of injury among plaintiffs but
accepted the settlement anyway.9 This willingness to accept class
settlements that ostensibly conflicted with the certification
requirements of Rule 23 was later rejected by the Supreme Court in
Amchem.92 Also, subsequent amendments to Rule 239" as well as
CAFA94 require courts to apply a heightened analysis to proposed
class settlements in order to protect the interests of absent class
members.95 Accordingly, the requirement that courts determine the
fairness of settlement procedures that might not always
accommodate these variations has placed a further layer of
regulatory responsibility upon courts.96
2. Choice-of-Law Issues
Concerns over the potential scope of a proposed class underlie
the policy decisions inherent to almost all of Rule 23's requirements.
The most common sticking point in the analysis of consumer product
class actions is the choice-of-law problem that comes with any
nationwide class action based on state law. As noted by Judge
90. See In re Factor VIII or IX Concentrate Blood Prods. Litig., 159 F.3d 1016, 1018 (7th
Cir. 1998).
91. Id. Some commentators have speculated that the Seventh Circuit was willing to accept
the Rhone-Poulenc settlement because the court was comfortable with a private, mutual
resolution that was not agreed to under the pressure of class certification. See Lahav, supra note
42, at 420-21.
92. See Amchem, 521 U.S. at 620.
93. See FED. R. CIV. P. 23(e).
94. See Pub. L. No. 109-2, 119 Stat. 4 (2005) (codified as amended in scattered sections of
28 U.S.C.).
95. See, e.g., In re Diet Drugs, No. 1203, 2000 U.S. Dist. LEXIS 12275, at *207 (E.D. Pa.
Aug. 28, 2000) (where the court evaluated and approved a class settlement regarding the health
effects of two prescription diet drugs).
96. In examining the proposed Vioxx settlement, Part E will also look at the ramifications of
not having a court thoroughly examine the ultimate fairness of mass consumer product
settlements that are not brought forth under class treatment but may ultimately diminish
plaintiffs' legal options.
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Fallon in denying nationwide class certification in Vioxx, "[A]
choice-of-law analysis presents significant hurdles to certification of
a nationwide class ... because the application of the laws of fifty-
one jurisdictions to the claims of the proposed class creates problems
for the typicality, adequacy, predominance, and superiority
requirements of Rule 23.""7 While federal courts holding diversity
jurisdiction must apply the choice-of-law statutes adopted by the
state in which they are sitting,98 most state choice-of-law statutes
require an evaluation of other states' competing interests in enforcing
their own laws, particularly over harms occurring within their
borders.99 While the analysis of such a question within an individual
suit would necessarily involve a choice of a particular state's law,
such an analysis in the class certification context has increasingly led
to an outright bar on nationwide class actions because no single
state's interest can be found to predominate.' 0 Inherent within such
a judgment, however, is a policy determination that the interests of
the individual states should weigh more heavily than either the
interests of the nationwide class in aggregating their claims or the
interests of an individual state in adjudicating the possible bad acts of
a corporate citizen.'
3. Protection of Class Members' Rights
The third major policy issue woven within 23(a)'s requirements
is the protection of class members' rights, particularly those
members who are uninvolved and may in fact be completely unaware
97. In re Vioxx Prods. Liab. Litig., 239 F.R.D. at 459 (citing Castano v. Am. Tobacco Co.,
84 F.3d 734, 741 (5th Cir. 1996)).
98. See Klaxon Co. v. Stentor Elec. Mfg. Co., 313 U.S. 487,496-97 (1941).
99. See, e.g., In re Bridgestone/Firestone, Inc., Tires Prods. Liab. Litig., 288 F.3d 1012,
1016 (7th Cir. 2002) (analyzing Indiana's choice-of-law provisions and its underlying lex loci
delicti principle); In re Vioxx Prods. Liab. Litig., 239 F.R.D. at 455 (detailing New Jersey's
choice-of-law provisions).
100. See Jeremy T. Grabill, Multistate Class Actions Properly Frustrated by Choice-of-Law
Complexities: The Role of Parallel Litigation in the Courts, 80 TUL. L. REV. 299, 309-311
(2005).
101. See In re Vioxx Prods. Liab. Litig., 239 F.R.D. at 455-58; see also In re Bridgestone/
Firestone Inc. Tires Prods. Liab. Litig., 288 F.3d at 1015-19 (rejecting a district court's
evaluation that the efficiency of class treatment should hold greater weight than the difficulties
inherent to acts occurring across multiple states).
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of the litigation."°2 While notification requirements and the ability to
opt out of the class form a significant part of Rule 23,'03 concerns
over the potential lost opportunity for uninvolved class members to
adequately assert their claims following a judgment or settlement
underlie much of courts' Rule 23(a) analysis." Yet these
considerations require courts to estimate not only the extent of the
potential classes' claims but also the extent of future class members'
damages."'
As expressed in Congress's stated reasoning for CAFA, there is
also significant concern over abuses in which class counsel negotiate
"settlements that offer little-if any-meaningful recovery to the
class members and simply transfer money from corporations to class
counsel."'0 6  Indeed, appellate courts have voiced concern over
settlements alleged to have been reached through "'reverse auction,'
the practice whereby the defendant in a series of class actions picks
the most ineffectual class lawyers to negotiate a settlement with in
the hope that the district court will approve a weak settlement that
will preclude other claims against the defendant."'0 7
Potential objectors to a class settlement or even future collateral
attacks upon the settlement have largely been shown to be ineffective
means to safeguard the interests of absent class members. 8 As such,
class action settlements impose an exceptional duty on courts to act
as a regulator, evaluating present, absent, and future interests at stake
in any class settlement. As the Seventh Circuit has noted, "we and
102. See Amchem, 521 U.S. at 626 n.20 (stating that one of the goals of 23(a)'s requirements
is to ensure "that the interests of the class members will be fairly and adequately protected in their
absence").
103. FED. R. Civ. P. 23(c)(2)(B).
104. See Amchem, 521 U.S. at 616.
105. See id. at 626 (identifying one of the major problems with the proposed global asbestos
settlement as the lack of sufficient protection for the future injuries of plaintiffs who had been
exposed to asbestos but had not yet developed injury); see also In re Diet Drugs, No. 1203 2000
U.S. Dist. LEXIS 12275, *140-44 (E.D. Pa. Aug. 28, 2000) (where the court found that a diet
drugs settlement overcame the problems of future plaintiffs that derailed the Amchem settlement
by creating detailed compensation rights for class members who developed future injuries).
These compensation rights for future injuries, however, have caused the settlement total to
substantially increase over time. See Addition to Wyeth Fen-Phen Fund Approved, N.Y. TIMES,
May 25, 2006, at C3.
106. S. REP. No. 109-14, at 4 (2005), reprinted in 2005 U.S.C.C.A.N. 3, 6.
107. Reynolds v. Benefit Nat'l Bank, 288 F.3d 277, 282 (7th Cir. 2002).
108. See Lonny Sheinkopf Hoffman, Syngenta, Stephenson and the Federal Judicial
Injunctive Power, 37 AKRON L. REv. 605, 650 (2004).
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other courts have gone so far as to term the district judge in the
settlement phase of a class action suit a fiduciary of the class, who is
subject therefore to the high duty of care that the law requires of
fiduciaries."'' 9 Such a role is obviously far removed from courts'
traditional role as neutral arbiters.
4. Settlement Pressures
As federal courts have evaluated the additional class
certification requirements of Rule 23(b)(3), problematic issues
inherent to the very nature of consumer class actions have been
raised. Indeed, in Rhone-Poulenc, Judge Posner put forth two
arguments regarding inherent conflicts presented by the number of
claims involved in the litigation, which ultimately seemed to
influence the rationale behind CAFA ten years later. First, class
certification would have added roughly 9000 additional plaintiffs
(twenty-five times the roughly 400 original plaintiffs who had
individually brought suit) without any indication that a significant
percentage of the class was actually seeking redress from the drug
companies." 0 Second, 400 individual claims, while potentially quite
costly, were unlikely to bankrupt the entire industry, whereas 10,000
claims aggregated in a class certainly had that potential."' Factoring
in the limited success of plaintiffs' prior individual suits,"2 the
Seventh Circuit estimated that a grant of class certification on the
issue would increase the industry's potential liability from roughly
$125 million in defending 300 individual suits to at least $25 billion
in defending one certified class action."3 Stating that such a drastic
potential liability would place defendants "under intense pressure to
settle," Judge Posner underscored how class certification itself can
become more important to the resolution of a consumer product issue
109. Reynolds, 288 F.3d at 279-80.
110. In re Rhone-Poulenc Rorer Inc., 51 F.3d 1293, 1296-300 (7th Cir. 1995).
111. Id.
112. Id. at 1299 ("A notable feature of this case, and one that has not been remarked upon or
encountered, so far as we are aware, in previous cases, is the demonstrated great likelihood that
the plaintiffs' claims, despite their human appeal, lack legal merit. This is the inference from the
defendants' having won 92.3 percent (12/13) of the cases to have gone to judgment."). This
evaluation of the merit of plaintiffs' claim within the analysis of class certification was very
controversial. See JoEllen Lind, "Procedural Swift ": Complex Litigation Reform, State Tort
Law, and Democratic Values, 37 AKRON L. REV. 717, 761-62 (2004).
113. In re Rhone-Poulenc, 51 F.3d at 1298-99.
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than the actual merit of the claims." 4 This contention is supported by
the fact that certified class actions generally settle shortly after
certification."5  Indeed, the court used this "blackmail" effect"6 of
class certification to help justify the extraordinary step of granting a
writ of mandamus to bar class certification." 7 "The reason that an
appeal will come too late to provide effective relief for these
defendants is the sheer magnitude of the risk to which the class
action, in contrast to the individual actions pending or likely, exposes
them." ' 8
5. Fair and Efficient Adjudication
The concern over this increase in overall magnitude through the
aggregation of claims strikes right at the heart of the policy issues
underlying Rule 23(b)(3), namely that "a class action is superior to
other available methods for the fair and efficient adjudication of the
controversy...... As some commentators have noted, "[e]vidence
indicates that the aggregation of claims increases both the likelihood
that a defendant will be found liable and the size of any damages
award that may result. Defendants are far more likely to be found
liable in cases with large numbers of plaintiffs than in cases
involving one or just a few plaintiffs.' 2 °
In evaluating the merits of class certification, some courts have
even espoused the benefits of the "diversified decisionmaking"
created through a decentralized litigation process over the judicial
114. Id. at 1298.
115. See Thomas E. Willging et al., An Empirical Analysis of Rule 23 to Address the
Rulemaking Challenges, 71 N.Y.U. L. REv. 74, 143 (1996) ("[C]ertified class actions were two to
five times more likely to settle than cases that contained class allegations but were never certified.
The percentage of certified class actions terminated by a class settlement ranged from 62% to
100%, while settlement rates (including stipulated dismissals) for cases not certified ranged from
20% to 30%."); see also Bryant G. Garth, Studying Civil Litigation Through the Class Action, 62
IND. L.J. 497, 501-04 (1987).
116. In re Rhone-Poulenc, 51 F.3d at 1298 (quoting the term "blackmail settlement" from
HENRY J. FRIENDLY, FEDERAL JURISDICTION: A GENERAL VIEW 120 (1973)).
117. Id. at 1294-95 (holding that a writ of mandamus is an extraordinary judicial act but
nonetheless warranted in the particular case). It should be noted that Rule 23 subsection () was
amended in 1998 to allow for interlocutory appeal of decisions regarding class certification. See
FED. R. CIv. P. 23(f) advisory committee's notes on 1998 amendments.
118. In re Rhone-Poulenc, 51 F.3d at 1297.
119. FED. R. CIV. P. 23(b)(3).
120. Victor E. Schwartz et al., Federal Courts Should Decide Interstate Class Actions: A Call
for Federal Class Action Diversity Jurisdiction Reform 37 HARV. J. ON LEGIS. 483, 491-92
(2000).
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efficiency provided by claim aggregation.'21 As detailed by the
Seventh Circuit in Rhone-Poulenc:
One jury, consisting of six persons (the standard federal
civil jury nowadays consists of six regular jurors and two
alternates), will hold the fate of an industry in the palm of
its hand. This jury, jury number fourteen, may disagree
with twelve of the previous thirteen juries-and hurl the
industry into bankruptcy. That kind of thing can happen in
our system of civil justice (it is not likely to happen,
because the industry is likely to settle-whether or not it
really is liable) without violating anyone's legal rights. But
it need not be tolerated when the alternative exists of
submitting an issue to multiple juries constituting in the
aggregate a much larger and more diverse sample of
decision-makers .... With the aggregate stakes in the tens
or hundreds of millions of dollars, or even in the billions, it
is not a waste of judicial resources to conduct more than
one trial, before more than six jurors, to determine whether
a major segment of the international pharmaceutical
industry is to follow the asbestos manufacturers into
Chapter 11.122
In furtherance of this view, some courts have relied upon a
series of initial "bellwether" trials in order to help formulate a more
balanced overall settlement.123
As discussed in Part I, this approach was used in the Vioxx
litigation, with a tentative settlement reached following twenty-one
initial trials.'24 Yet the Vioxx settlement was likely based as much
on judicial pressure as it was on the results of the initial trials.2 5
Further, as will be discussed in Part V, there are elements of the
agreement that radically affect the interests of all plaintiffs, even
though the settlement is not class based.'26 Accordingly, courts are
121. In re Bridgestone/Firestone, Inc., Tires Prods. Liab. Litig., 288 F.3d 1012, 1019-20 (7th
Cir. 2002).
122. In re Rhone-Poulenc, 51 F.3d at 1300.
123. See In re Chevron U.S.A., Inc., 109 F.3d 1016, 1019-20 (5th Cir. 1997) (describing the
process by which bellwether trials are used to help craft an ultimate settlement).
124. See Berenson, Settlement, supra note 30.
125. See Nocera, supra note 35.
126. See Alex Berenson, Lawyers Seek to Alter Settlement over Vioxx, N.Y. TIMES, Dec. 21,
2007, at C4 (noting complaints over a provision of the settlement which requires plaintiff
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faced with a range of policy concerns in even these ostensibly
private, mutual settlements that parallel many of the concerns faced
in evaluating a class-based settlement.
B. The Federalism Tensions Inherent Within Class Certification
The precarious balancing of policy issues that has been
presented so far has focused only on federal courts' interpretation of
Rule 23. Yet state courts and their individual class action rules were
a key part of the turmoil that eventually led to CAFA.' 27 The reason
is that some state courts have evaluated the policy concerns detailed
above much differently than federal courts and extended certification
to classes, even nationwide classes with clear choice-of-law
problems, 128 that would normally not be certified in federal courts.'29
For instance, some state courts have re-focused traditional choice-of-
law analysis by attributing greater value to the interests of a home
state in having its regulations applied to a citizen manufacturer. 3' In
so doing, however, these courts have imposed an individual state's
regulatory schemes upon the remaining forty-nine states and their
citizens, creating horizontal federalism tensions between the states.
With plaintiffs bringing parallel actions in both state and federal
courts and pursuing collateral attacks on federal certification
decisions, federal courts have also been left in the tenuous position of
attempting to enforce their decisions through the All Writs Act 3'
while not upsetting the balance of federalism demanded by the Anti-
attorneys to recommend the settlement to all of their clients and to withdraw from representing
any client who chooses to litigate further rather than accept the settlement) [hereinafter Berenson,
Alteration]; see also Adam Liptak, In Vioxx Settlement, Testing a Legal Ideal: A Lawyer's
Loyalty, N.Y. TIMES, Jan. 22, 2008, at A 12 (discussing the legal ethics of such a requirement).
127. S. REP. No. 109-14, at 6-23 (2005), reprinted in 2005 U.S.C.C.A.N. 3, 7-23.
128. See, e.g., White v. Gen. Motors Corp., 97-1028, p. 5-6 (La. App. I Cir. 6/29/98), 718 So.
2d 480 (approving a nationwide consumer product settlement previously rejected by the Third
Circuit in In re General Motors Corp. Pick-up Truck Fuel Tank Products Liability Litigation, 55
F.3d 768, 777 (3rd Cir. 1995)); see also Rhonda Wasserman, Dueling Class Actions, 80 B.U. L.
REv. 461, 465-70 (2000) (detailing the story of the competing class actions involving side-
mounted fuel tanks on General Motors pickup trucks).
129. See Vairo, Judicial v. Congressional, supra note 59, at 1598-600 (identifying a more
receptive approach to class certification within certain state courts).
130. See Ysbrand v. DaimlerChrysler Corp., 2003 OK 17, 15, 81 P.3d 618, 625-26 ("[T]he
relative interest of each buyer's home state in applying its version of the UCC is more or less
equal. By contrast, Michigan's interest in having its regulatory scheme applied to the conduct of
a Michigan manufacturer is most significant.").
131. 28 U.S.C. § 1651 (2000).
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Injunction Act.'32  As such, the secondary effects of class
certification have created myriad federalism problems.
1. Extending the Borders of State Law
In discussing the drive to replace the Articles of Confederation
with a reformulated constitution, Justice Brennan noted that "a
central concern of the Framers ... [was] the conviction that in order
to succeed, the new Union would have to avoid the tendencies
toward economic Balkanization that had plagued relations among the
Colonies and later among the States under the Articles of
Confederation."'33  While "federalism" has meant many things to
different commentators,'34 part of the initial push towards a stronger
federal government described by Justice Brennan must have included
the desire to prevent states from unilaterally exporting their policy
decisions across state lines. This view was certainly taken by
Congress in drafting CAFA. 35 In decrying an Alabama court's
certification of a nationwide class action regarding defective airbags,
the Senate Judiciary Committee's report in support of the legislation
asked, "Why should an Alabama state court tell 20 million people in
all 50 states what kind of airbags they can have in their cars?"'36
Labeling such state court decisions as "false federalism," the drafters
of CAFA argued that state court certification of nationwide class
actions "flies in the face of basic federalism principles by embracing
the view that other states should abide by a deciding court's law
whenever it decides that its own laws are preferable to other states'
contrary policy choices. '""' Yet not only can the certification of
nationwide classes by state courts have such an effect, they can also
132. Id. § 2283; see also Joshua J. Wes, The Anti-Injunction and All Writs Act in Complex
Litigation, 37 LOY. L.A. L. REV. 1603 (2004) (discussing the case history of the Anti-Injunction
and All Writs Acts as they have been employed in parallel class action cases).
133. Hughes v. Oklahoma, 441 U.S. 322, 325 (1979).
134. See ROBERT W. HOFFERT, A POLITICS OF TENSIONS: THE ARTICLES OF
CONFEDERATION AND AMERICAN POLITICAL IDEAS, at xi (1992) ("A feast of 'federalisms' has
been offered up to the American public. Dual federalism, national-supremacy federalism, marble
cake federalism, new federalism, picket-fence federalism, and crazy quilt federalism are just some
of the 'flavors."'); see also Richard W. Garnett, The New Federalism, the Spending Power, and
Federal Criminal Law, 89 CORNELL L. REV. 1, 11-23 (2003) (discussing the Supreme Court's
current view of federalism as a limitation on the federal government's intrusion into traditionally
state areas of governance).
135. Class Action Fairness Act, 28 U.S.C. §§ 1711-15 (2005).
136. S. REP. NO. 109-14, at 24 (2005), reprinted in 2005 U.S.C.C.A.N. 3, 24.
137. Id. at26.
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work to limit the recovery of an out-of-state class member who may
have had no substantial contacts with the jurisdiction. 38 As such,
class certification decisions by state courts can have significant
interstate commerce effects that result in state judicial regulation of
national industries and interests.1
39
2. The Muddy Line Between State and Federal Control
Over Class Certification
Some state courts have effectively undermined federal court
decisions regarding class certification. In instances where federal
courts (and even other state courts) have denied class certification for
a nationwide class, plaintiffs have continued to shop their action until
finding a state court willing to certify. 4 ' For example, a settlement
class involving fuel tanks in General Motors pickups was eventually
certified in Louisiana after first having been rejected by both the
Third Circuit and Texas state courts. 4 ' As Judge Easterbrook of the
Seventh Circuit described the scenario:
Relitigation can turn even an unlikely outcome into reality.
Suppose that every state in the nation would as a matter of
first principles deem inappropriate a nationwide class
covering these claims and products. What this might mean
in practice is something like "9 of 10 judges in every state
would rule against certifying a nationwide class" (in the
federal courts, it has meant that 3 of 4 judges have ruled
against the proposed nationwide classes). Although the
10% that see things otherwise are a distinct minority, one is
bound to turn up if plaintiffs file enough suits-and, if one
nationwide class is certified, then all the no-certification
138. See Phillips Petroleum Co. v. Shuns, 472 U.S. 797, 811-13 (1985) (holding that a state
can exercise jurisdiction over absent class members, "even though that plaintiff may not possess
the minimum contacts with the forum which would support personal jurisdiction over a
defendant," so long as the minimum constitutional requirements of notice and opportunity to be
heard are met).
139. See Nagareda, supra note 37, at 192 (arguing that the use of class actions undermines
politically accountable regulatory agencies); Schwartz & Lorber, supra note 37, at 1215-18
(discussing the use of litigation to regulate industries).
140. See supra note 128 and accompanying text.
141. White v. Gen. Motors Corp., 97-1028, p. 8-9 (La. App. 1 Cir. 6/29/98), 718 So. 2d 480.
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decisions fade into insignificance. A single positive trumps
all the negatives." 2
As such, plaintiffs' ability to seek nationwide certification in
multiple forums, often overlapping with each other, creates
significant barriers to defendants' ability to ever completely defeat
the threat of class certification, wasting judicial resources 143 and
undercutting the authority of federal court decisions along the way.
1 44
In acting to protect the preclusive effect of their decisions,
federal courts have been left with options that necessarily entail
precarious issues of federalism. The All Writs Act allows for federal
courts to issue orders "necessary or appropriate in aid of their
respective jurisdictions and agreeable to the usages and principles of
law. ' 145 Yet this tool for bolstering the efficiency of federal courts
was traditionally viewed quite narrowly, particularly in regards to
interference with state courts.1 46  Indeed, the Anti-Injunction Act
directly limited the scope of the All Writs Act as it could be applied
to enjoin state court actions: "A court of the United States may not
grant an injunction to stay proceedings in a State court except as
expressly authorized by Act of Congress, or where necessary in aid
of its jurisdiction, or to protect or effectuate its judgments.' 47 More
broadly, the right to maintain separate judicial systems was one of
the sovereign powers retained by the states under the Constitution.48
As such, tensions created by conflicting decisions over class
certification have made it difficult to efficiently adjudicate
nationwide class actions without upsetting the federalism balance
between state and federal courts. In combination with the balance of
142. In re Bridgestone/Firestone, Inc. Tires Prods. Liab. Litig., 333 F.3d 763, 766-767 (7th
Cir. 2003) (emphasis omitted).
143. See James M. Underwood, Rationality, Multiplicity & Legitimacy: Federalization of the
Interstate Class Action, 46 S. TEX. L. REv. 391, 408-411 (2004) (describing the concerns
associated with multiple overlapping class actions involving the same issue and prospective
class).
144. See infra Part C (discussing in detail the Supreme Court's decision regarding the balance
of power between state and federal courts).
145. 28 U.S.C. § 1651 (2000).
146. See Wes, supra note 132, at 1622-24. The Supreme Court has also refused to allow the
use of the All Writs Act to support removal of state actions to federal court. See infra Part C; see
also Syngenta Crop Prot., Inc. v. Henson, 537 U.S. 28 (2002).
147. 28 U.S.C. § 2283 (2000); see also Atlantic Coast Line R.R. Co. v. Bd. of Locomotive
Eng'rs, 398 U.S. 281 (1970) (detailing the limits of federal court powers to enjoin state court
action).
148. See Atlantic Coast Line, 398 U.S. at 285.
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policy considerations discussed earlier, the federalism tensions
inherent in class certification decisions compounded the burden
facing the Supreme Court and ultimately Congress in resolving these
issues.
III. THE BIPOLAR APPROACH OF FEDERAL COURTS TO
CLASS CERTIFICATION
In examining the Supreme Court's approach to these various
aspects of class action litigation prior to CAFA, it becomes clear that
the Court eventually succeeded in effectively sorting out only part of
this policy puzzle. The Court's 1985 decision in Phillips Petroleum
Co. v. Shutts'49 in particular highlighted trends that would prove to be
significant to this issue. In Shutts, a Kansas trial court certified a
class of some 28,000 plaintiffs spread across all fifty states and
several foreign countries who all owned interests in natural gas
deposits leased by the defendant. 5 Incorporated in Delaware with
its principal place of business in Oklahoma, the defendant gas
company produced gas in eleven different states and sold most of it
in interstate commerce, making royalty payments to plaintiffs
according to the price charged.15' While awaiting approval from the
Federal Power Commission for price increases already in place,
however, defendant maintained royalty rates at their prior levels.
15 2
Following subsequent agency approval of the rate increases,
plaintiffs sought interest on the back royalty payments.'53 Finding
for the plaintiff royalty owners, the trial court awarded the class rates
of interest based on Kansas law, resulting in an average award of
$100 per royalty owner.'54
In overturning the Supreme Court of Kansas's decision to
uphold the trial judgment, the Supreme Court made two holdings that
each significantly affected the future course of class action litigation,
but in ultimately contradictory ways. First, the Supreme Court
upheld the state court's jurisdiction over the thousands of plaintiffs
who owned no land in Kansas and lacked any contacts with the
149. 472 U.S. 797 (1985).
150. Id. at 799.
151. Id. at 799-801.
152. Id.
153. Id.
154. Id. at 801-802.
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forum, finding that reasonable efforts to notify class members and
allow them to opt out were sufficient to satisfy due process
requirements for absent class members. 55  Next, however, the
Supreme Court rejected the reasoning of the Supreme Court of
Kansas that a finding of jurisdiction created a presumption that "the
law of the forum should be applied unless compelling reasons exist
for applying a different law."' 56  Arguing instead that such a
presumption improperly overcame Rule 23's commonality
requirement through a "bootstrap argument,"'57  then Justice
Rehnquist wrote for the court:
[A state] may not take a transaction with little or no
relationship to the forum and apply the law of the forum in
order to satisfy the procedural requirement that there be a
"common question of law." The issue of personal
jurisdiction over plaintiffs in a class action is entirely
distinct from the question of the constitutional limitations
on choice of law; the latter calculus is not altered by the fact
that it may be more difficult or more burdensome to comply
with the constitutional limitations because of the large
number of transactions which the State proposes to
adjudicate and which have little connection with the
forum. 1
58
Accordingly, the Supreme Court found the choice of Kansas law
as "arbitrary" due to the lack of contact between the state and the
majority of class claims1 59 but found no similar "arbitrariness" bar to
state jurisdiction over the class, despite the same demonstrated lack
of contact. 6° Implicit within this analysis is the Court's reliance on
the procedural safeguards of class certification, rather than
155. Id. at 811-12 ("[A] forum State may exercise jurisdiction over the claim of an absent
class-action plaintiff, even though that plaintiff may not possess the minimum contacts with the
forum which would support personal jurisdiction over a defendant.").
156. Shutts v. Phillips Petroleum Co., 679 P.2d 1159, 1181 (Kan. 1984).
157. Phillips, 472 U.S. at 821 (internal quotation marks omitted).
158. Id.
159. Id. at 821-22. The court noted that 99 percent of the gas leases and 97 percent of the
plaintiffs had no apparent connection to the state of Kansas. Id. at 815-16.
160. Id. at 806-812.
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jurisdictional safeguards, to properly protect the interests of absent
class members. 1 '
This divergence in the importance of "forum contacts" as
respectively applied to personal jurisdiction and choice-of-law
signaled future trends within class action litigation that would
ultimately come into conflict. As a result of the Shutts decision,
Kansas could assert jurisdiction over a nationwide class of plaintiffs
but was limited in its ability to adjudicate such a nationwide
controversy if following the Court's increasingly restrictive choice-
of-law analysis. 62
Yet Justice Stevens's dissent in the case,163 as well as the
subsequent litigation involving the parties,"6 reflects the latitude that
state courts still retained in interpreting other states' laws and the
procedural requirements associated with class actions.'65 As will be
discussed, the Court made no clear attempt to prevent state courts
from asserting independent control over the adjudication of
nationwide classes, even when such state adjudication conflicted
with the analysis applied in federal courts. Accordingly, as the
Supreme Court heightened the requirements necessary for class
certification in subsequent cases, state courts were not required to
161. Id. at 809 ("A plaintiff class in Kansas and numerous other jurisdictions cannot first be
certified unless the judge, with the aid of the named plaintiffs and defendant, conducts an inquiry
into the common nature of the named plaintiffs' and the absent plaintiffs' claims, the adequacy of
representation, the jurisdiction possessed over the class, and any other matters that will bear upon
proper representation of the absent plaintiffs' interest.").
162. Id. at 821-22 (holding that a state "must have a 'significant contact or significant
aggregation of contacts' to the claims asserted by each member of the plaintiff class, contacts
'creating state interests,' in order to ensure that the choice of [the state's] law is not arbitrary or
unfair" (quoting Allstate Ins. Co. v. Hague, 449 U.S. 302, 312-13 (1981))).
163. Id. at 834-38 (Stevens, J. concurring in part and dissenting in part) ("This Court, of
course, can have no concern with the substantive merits of common-law decisions reached by
state courts faithfully applying their own law or the law of another State. When application of
pureiy stite law is at issue, '[t]he power delegated to us is for the restraint of unconstitutional
[actions] by the States, and not for the correction of alleged errors committed by their judiciary."'
(quoting Commercial Bank of Cincinnati v. Buckingham's Ex'rs, 46 U.S. (5 How.) 317, 343
(1847)).
164. Sun Oil Co. v. Wortman, 486 U.S. 717, 730-731 (1988) ("To constitute a violation of
the Full Faith and Credit Clause or the Due Process Clause, it is not enough that a state court
misconstrue the law of another State. Rather, our cases make plain that the misconstruction must
contradict law of the other State that is clearly established and that has been brought to the court's
attention.").
165. Id. at 722 ("Since the procedural rules of its courts are surely matters on which a State is
competent to legislate, it follows that a State may apply its own procedural rules to actions
litigated in its courts.").
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follow this trend. As such, the Supreme Court's reluctance to clearly
define the judicial balance of federalism associated with the
adjudication of nationwide class actions allowed state courts to
undermine the federal approach towards class certification.
A. The Move in Federal Courts Towards Restricting
Class Certification
Over the twenty-year period between the 1966 modifications to
Rule 23 and the Supreme Court's decision in Shutts, federal courts
had generally been reluctant to allow the use of class actions as a
way to manage consumer product actions involving large numbers of
plaintiffs from across the country. 66 Indeed, the members of the
1966 Advisory Committee did not think that the modified Rule 23
would generally be appropriate for use with consumer product
claims. 67 Accordingly, the Court's restrictive choice-of-law analysis
in Shutts matched prior trends within the federal courts limiting the
scope of class action litigation. As mentioned earlier, however,
federal courts were faced with a series of mass consumer product
controversies in the mid-1980s through the early 1990s that
overwhelmed judicial resources. 68 In the face of efficiency problems
created by the sheer numbers of these individual cases, 69 federal
courts became more amenable to class certification for a time,
largely because of the increases in group settlements that
accompanied class certification. 7° As stated by the district court
managing the Agent Orange litigation, "a classwide finding of
causation may serve to resolve the claims of individual members, in
a way that determinations in individual cases would not, by
enhancing the possibility of settlement among the parties ....
This ultimately short-lived trend in federal courts towards granting
class certification was driven by regulatory policy considerations
favoring efficiency in managing these broad, national
166. See Vairo, Judicial v. Congressional, supra note 59, at 1568-70.
167. 2 COMM. ON RULES OF PRACTICE AND PROCEDURE, supra note 47, at 260.
168. See supra notes 55-58 and accompanying text.
169. See, e.g., In re "Agent Orange" Prod. Liab. Litig., 597 F. Supp. 740, 749-50 (E.D.N.Y.
1984) ("Some 600 separate cases have been sent to this district from all over the country with an
estimated fifteen thousand named plaintiffs.").
170. See Vairo, Judicial v. Congressional, supra note 59, at 1573-74.
171. In re "Agent Orange" Prod. Liab. Litig., 100 F.R.D. 718, 723 (E.D.N.Y. 1983).
1066
Spring 2008] CONSUMER PRODUCT PAIN RELIEF
controversies.1 72 As summarized by the Fifth Circuit in evaluating
the overwhelming number of asbestos cases flooding both state and
federal courts:
Courts have usually avoided class actions in the mass
accident or tort setting. Because of differences between
individual plaintiffs on issues of liability and defenses of
liability, as well as damages, it has been feared that separate
trials would overshadow the common disposition for the
class. The courts are now being forced to rethink the
alternatives and priorities by the current volume of
litigation and more frequent mass disasters. If Congress
leaves us to our own devices, we may be forced to abandon
repetitive hearings and arguments for each claimant's
attorney to the extent enjoyed by the profession in the
past.1
73
The Supreme Court's 1997 decision in Amchem, however,
marked the Court's unease with this expanding regulatory role and
definitively swung federal courts back towards the more critical
analysis of class certification requirements exhibited in Shutts.174 In
rejecting a class action settlement of the "asbestos-litigation crisis"
facing courts at that time, 75 Justice Ginsburg began the majority
opinion by noting the conclusion of the Ad Hoc Committee on
Asbestos Litigation176 that a real solution to the controversy "required
federal legislation creating a national asbestos dispute-resolution
scheme.' ' 77 Pointedly stating that "[t]o this date, no congressional
response has emerged," Justice Ginsburg framed the expanding use
of class certification by lower courts as efforts to create national
172. See Vairo, Judicial v. Congressional, supra note 59, at 1573-74.
173. Jenkins v. Raymark Indus., Inc., 782 F.2d 468, 473 (5th Cir. 1986) (citations omitted).
174. Amchem Prods., Inc. v. Windsor, 521 U.S. 591, 611-28 (1997) (upholding
decertification of a settlement class of plaintiffs affected by asbestos exposure).
175. Id. at 597.
176. The Ad Hoc Committee on Asbestos Litigation was appointed by Chief Justice
Rehnquist in September 1990 and prepared a report outlining the judicial problems associated
with the wave of asbestos exposure litigation that began during the 1970s. See AD HOC COMM.
ON ASBESTOS LITIG., REPORT OF THE JUDICIAL CONFERENCE AD HOC COMMITTEE ON
ASBESTOS LITIGATION 2-3 (1991).
177. Amchem, 521 U.S. at 598.
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regulatory solutions not authorized by Congress.7 ' The Amchem
decision restricted these efforts by clearly rejecting the policy
interest in promoting broad settlements at the expense of the
requirements of Rule 23:
The predominance requirement stated in Rule 23(b)(3), we
hold, is not met by the factors on which the District Court
relied. The benefits asbestos-exposed persons might gain
from the establishment of a grand-scale compensation
scheme is a matter fit for legislative consideration, but it is
not pertinent to the predominance inquiry. That inquiry
trains on the legal or factual questions that qualify each
class member's case as a genuine controversy, questions
that preexist any settlement.'79
In holding that the requirements of Rule 23 could not be
weakened by policy considerations favoring class settlements, the
Amchem decision significantly limited the ability of federal courts to
effectively provide solutions to broad consumer product
controversies. As noted in Justice Breyer's dissent, individual
adjudication of asbestos claims had led to "[d]elays, high costs, and a
random pattern of noncompensation," at the same time absorbing a
vast amount of judicial resources. tS While noting these concerns,"'
the majority was unwilling to expand the role of courts to include the
regulatory authority necessary to oversee an effective compromise.
As Justice Ginsburg wrote in concluding the opinion:
The argument is sensibly made that a nationwide
administrative claims processing regime would provide the
most secure, fair, and efficient means of compensating
victims of asbestos exposure. Congress, however, has not
adopted such a solution. And Rule 23, which must be
interpreted with fidelity to the Rules Enabling Act and
applied with the interests of absent class members in close
view, cannot carry the large load.., heaped upon it.'82
178. Id. at 598-99 ("In the face of legislative inaction, the federal courts-lacking authority to
replace state tort systems with a national toxic tort compensation regime-endeavored to work
with the procedural tools available to improve management of federal asbestos litigation.").
179. Id. at 622-23 (citations omitted).
180. Id. at 631-32 (Breyer, J. concurring in part and dissenting in part).
181. Id.at629n.21.
182. Id. at 628-29.
1068
Spring 2008] CONSUMER PRODUCT PAIN RELIEF
Faced with the multitude of policy concerns inherent to class
certification, the majority chose to embrace a conservative approach
of strict adherence to Rule 23's requirements as a means of
protecting the role of courts as adjudicators, rather than regulators.
In so doing, the Court turned back the wave of class certifications
based on policy considerations and substantially limited the
regulatory scope of class action litigation.
B. The Federalism Dilemma
While the Supreme Court was clear in its determination to
enforce the requirements of Rule 23 in federal courts, federalism
concerns largely limited the ability of federal courts to require the
same restrictive view of class certification in state courts. With the
decision in Shutts upholding state court jurisdiction over classes of
nationwide plaintiffs, 8 3 state and federal courts increasingly came
into conflict over the issuance of final judgments or settlements
binding nationwide classes.184 While federal courts could employ
injunctions in certain instances, this power could not prevent states
from certifying classes rejected in federal courts. 5' Further, the
Supreme Court has refused to cross certain federalism boundaries,
limiting attempts to expand removal of state actions undermining
federal judgments relating to complex class litigation.'86
Consequently, the Supreme Court has not provided clear boundaries
between federal and state authority over nationwide class actions,
allowing state courts to significantly weaken the restrictive view of
class certification put forth by the Court in Amchem.
As prefaced in Part II, the ability of federal courts to use
injunctions under the All Writs Act to restrict state court actions is
183. Phillips Petroleum Co. v. Shutts, 472 U.S. 797, 811-12 (1985).
184. See Wes, supra note 132, at 1602.
185. See In re Gen. Motors Corp. Pick-Up Truck Fuel Tank Prods. Liab. Litig., 134 F.3d 133
(3d Cir. 1998) (rejecting the request for an injunction barring class settlement in Louisiana state
court where the class settlement had previously been rejected by the Third Circuit).
186. See Syngenta Crop Prot., Inc. v. Henson, 537 U.S. 28 (2002) (rejecting the use of the All
Writs Act to support removal). See generally Hoffman, supra note 108. The Supreme Court has
also narrowly upheld the right of absent class members to collaterally attack the adequacy of
federally approved class settlements through state court actions. See Dow Chem. Co. v.
Stephenson, 539 U.S. 111 (2003). With Justice Stevens taking no part in the decision, the Court
was evenly divided four votes to four, subsequently upholding the decision of the Second Circuit
in Stephenson v. Dow Chem. Co., 273 F.3d 249 (2d Cir. 2001). Id.
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significantly restricted by the Anti-Injunction Act.8 7 In the context
of class actions, federal courts have been able to make some use of
injunctions, but only where class settlement has been accepted or is
pending in the federal court.'88 The Second Circuit upheld an
injunction, for instance, to prevent the filing of state court suits that
might have undermined a pending settlement of a multidistrict
securities class action.'89 Further, the Third Circuit upheld an
injunction barring a Texas state court from approving a mass opt-out
of state class members from a nationwide class settlement of diet
drug claims approved by the Eastern District of Pennsylvania. 9 ° Yet
the power of federal courts to enjoin state court actions does not
extend to cases where the federal court has rejected class
certification. As was mentioned in Part II, a Louisiana state court
accepted a class settlement of claims involving fuel tanks in General
Motors pickups that had previously been rejected by both the Third
Circuit and Texas state courts. 9' On hearing the appeal of a group of
class objectors seeking to enjoin the Louisiana state court action, the
Third Circuit refused to extend the preclusive effect of its prior
judgment to state courts by way of injunction:'92 "[D]enial of class
certification under these circumstances lacks sufficient finality to be
entitled to preclusive effect. Second, the decision by this Court to
reject the provisional settlement class is not a 'judgment' with
respect to the Louisiana settlement agreement, and our interpretation
of Rule 23 is not binding on the Louisiana court.' 19 3 Indeed, this
holding was in keeping with prior Supreme Court rulings limiting the
"relitigation exception" of the Anti-Injunction Act.'94
Further, the Supreme Court has rejected the use of the All Writs
Act as a means of removing class action litigation to federal courts.'95
187. 28 U.S.C. § 1651 (2000).
188. See Wes, supra note 132, at 1633.
189. In re Baldwin-United Corp., 770 F.2d 328, 332-33 (2d Cir. 1985). While the Second
Circuit expressly evaluated the limitations imposed by the Anti-Injunction Act, it is not clear that
the act applies before state court actions have commenced. See Wes, supra note 132, at 1624-25.
190. In re Diet Drugs Prods. Liab. Litig., 282 F.3d 220 (3d Cir. 2002).
191. See supra note 128 and accompanying text.
192. In re Gen. Motors Corp. Pick-Up Truck Fuel Tank Prods. Liab. Litig., 134 F.3d 133 (3d
Cir. 1998).
193. Id. at 146.
194. See, e.g., Chick Kam Choo v. Exxon Corp., 486 U.S. 140, 147 (1988).
195. See Syngenta Crop Prot., Inc. v. Henson, 537 U.S. 28 (2002); see also Hoffman, supra
note 108, at 607-19.
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In Syngenta Crop Protection, Inc. v. Henson,96 plaintiffs who had
been actively involved in a class settlement of exposure claims
against a chemical company in the Southern District Court of
Alabama subsequently attempted to amend and maintain a previously
stayed Louisiana state court action against the company, despite
having agreed to dismiss with prejudice all their claims as part of the
federally approved settlement.'97 Faced with a state court judge
willing to assess plaintiffs' contention that their state claims were
distinct from those involved in the federal action, the chemical
company sought to remove the case to federal court based upon the
All Writs Act. 9' A unanimous Supreme Court definitively rejected
this expanded use of the All Writs Act, stating that the Act did not
"'by its specific terms, provide federal courts with an independent
grant of jurisdiction . . . . """ Indeed, Chief Justice Rehnquist noted
that outside of a federal court injunction, the chemical company
would have to rely upon the preclusion analysis of the state court:
"One in petitioners' position may apply to the court that approved a
settlement for an injunction requiring dismissal of a rival action.
Petitioners could also have sought a determination from the
Louisiana state court that respondent's action was barred by the
judgment of the Alabama District Court." ' As such, the Court has
granted state courts significant influence over many class actions,
while limiting the ability of defendants to protect prior victories on
class certification within federal courts. In so doing, the Court also
left its own restrictive analysis of class certification open to
reinterpretation by state courts with different policy views.
IV. CONGRESS RE-CALIBRATES THE BALANCE OF FEDERALISM
In the wake of Amchem,2 °' federal courts became very difficult
forums for parties seeking certification of nationwide classes or
approval of nationwide class settlements. 2 While some negative-
196. 537 U.S. 28 (2002).
197. Id. at 30.
198. Id.
199. Id. at 33 (quoting Brief for Petitioners at 9, Henson, 537 U.S. 28 (No. 01-757)).
200. Id. at 34 n*.
201. Amchem Prods., Inc. v. Windsor 521 U.S. 591 (1997).
202. See, e.g., Jackson v. Motel 6 Multipurpose, Inc., 130 F.3d 999, 1005 (1 1th Cir. 1997)
(relying on analysis from Amchem in decertifying class claiming race discrimination); Walker v.
Liggett Group, Inc., 175 F.R.D. 226, 228 (S.D. W. Va. 1997) (withdrawing prior approval of class
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value classes have been certified on a statewide basis, 2°3
controversies that can be managed through class actions in federal
courts appear to be severely limited in both their geographic scope
and range of injury.2° In fact, a recent survey found that only 22
percent of class actions removed to federal courts were certified for
either trial or settlement. 25 For consumer product claims, the federal
courts are particularly skeptical that a class could meet the
requirements of Rule 23.206
In contrast, state courts are commonly perceived as more
receptive to certifying nationwide class actions.20 7  As stated in the
Senate report regarding CAFA, "some state court judges are less
careful than their federal court counterparts about applying the
procedural requirements that govern class actions. 2 8 Indeed, this
perceived disparity in class action treatment between state and
federal courts has been shown to play a significant part in attorneys'
forum choices °.2 9  As a result, class action plaintiffs generally
focused their efforts on state courts following Amchem 1°
But state courts in general have not granted class certification at
a significantly higher rate than federal courts.21' Instead, the
perception of "drive-by class certification" 212 in state courts has been
settlement and certification of class of smokers following the decision in Amchem). See generally
Vairo, Judicial v. Congressional, supra note 59, at 1597-602.
203. See, e.g., Daffin v. Ford Motor Co., 458 F.3d 549 (6th Cir. 2006) (upholding certification
of a class of Ohio minivan owners claiming a potential defect devalued the vehicle); Smilow v.
Southwestern Bell Mobile Sys., Inc., 323 F.3d 32 (1st Cir. 2003) (overturning decertification of a
class of Massachusetts and New Hampshire cellular phone customers alleging breach of contract
claim for overcharges).
204. See generally Nicole Ochi, Developments, Are Consumer Class and Mass Actions
Dead? Complex Litigation Strategies After CAFA and MMTJA, 41 Loy. L.A. L. Rev: 965
(2008).
205. Thomas E. Willging & Shannon R. Wheatman, Attorney Choice of Forut in Class
Action Litigation: What Difference Does it Make?, 81 NOTRE DAME L. REV. 591, 635 (2006).
206. See Zinser v. Accufix Research Inst., Inc., 253 F.3d 1180, 1186 (9th Cir. 2001) ("Our
circuit has recognized the potential difficulties of 'commonality' and 'management' inherent in
certifying products liability class actions."); In re Am. Med. Sys., Inc., 1996 FED App. 0049P at
24-25 (6th Cir.) (noting that products liability classes present challenges for certification because
they usually involve factual and legal issues that vary from individual to individual).
207. See S. REP. No. 109-14, at 14 (2005), reprinted in 2005 U.S.C.C.A.N. 3, 14-15.
208. Id.
209. See Willging & Wheatman, supra note 205, at 602-14; Ochi, supra note 204.
210. See Vairo, Judicial v. Congressional, supra note 59, at 1597-99.
211. See Willging & Wheatman, supra note 205, at 635.
212. S. REP. No. 109-14, at 22 (2005), reprinted in 2005 U.S.C.C.A.N. 3, 22.
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fueled by a relatively small number of jurisdictions, labeled by
defendants as "judicial hellholes, ' ' 13 where judges have taken a
comparatively expansive view of class certification.214 In fact,
particular jurisdictions saw a dramatic spike in the number of class
actions filed in their districts following Amchem, as plaintiffs lawyers
sought out friendly forums for nationwide class certification.1 5
While there are no wide disparities between the rules adopted by
states and the federal courts,216 some state courts have clearly
interpreted the policy issues underlying class certification differently
than the Supreme Court.27  For instance, one state court in a county
particularly popular with plaintiffs found that "[t]he policy objective
behind class actions is to encourage individuals, who may otherwise
lack an incentive to file individual actions because their damages are
limited, to join with others to vindicate their rights in a single
action. ' 12 8  As such, some plaintiffs lawyers have gone to great
lengths to establish jurisdiction in particular state forums and protect
their actions from removal to federal courts.21 9
Congress reacted to these trends by attempting to move the
adjudication of most interstate class actions into federal courts,220
213. See AM. TORT REFORM ASS'N, JUDICIAL HELLHOLES 2007, at ii (2007), http://
www.atra.org/reports/hellholes/report.pdf. For an in depth discussion of judicial hellholes, see
Feit, supra note 73 at 922-25.
214. See S. REP. No. 109-14, at 13-14 (2005), reprinted in 2005 U.S.C.C.A.N. 3, 13-15
(identifying several of these "magnet" jurisdictions, such as Madison County, Ill.).
215. Id. (noting that the largely rural Madison County, Ill., for instance, saw the number of
class actions filed annually in the county rapidly increase from a total of 2 in 1998 to 106 in
2003).
216. See id.; Richard A. Nagareda, Aggregation and its Discontents: Class Settlement
Pressure, Class-Wide Arbitration, and CAFA, 106 COLUM. L. REV. 1872, 1913 (2006).
217. See Ysbrand v. DaimlerChrysler Corp., 2003 OK 17, 81 P.3d 618 (holding that class
certification is appropriate where the law of the defendant's home state could be applied to all
claims, even when the class includes members from all fifty states).
218. Phillips v. Ford Motor Co., No. 99-L-1041, 2003 WL 23353492, at *1 (111. Cir. Sept. 15,
2003) (emphasis added).
219. See Laura J. Hines & Steven S. Gensler, Driving Misjoinder: The Improper Party
Problem in Removal Jurisdiction, 57 ALA. L. REV. 779 (2006) (discussing the efforts of plaintiffs
to defeat removal by adding uninvolved parties in an effort to defeat complete diversity); James
M. Underwood, From Proxy to Principle: Fraudulent Joinder Reconsidered, 69 ALB. L. REV.
1013 (2006); see also S. REP. No. 109-14, at 10 (2005), reprinted in 2005 U.S.C.C.A.N. 3, 11
("One witness at the Committee's 2002 hearing on class actions testified that her drug store was
named as a defendant in 'hundreds of lawsuits' so that 'the lawyers could keep the case in a place
known for its lawsuit-friendly environment.").
220. See S. REP. No. 109-14, at 5 (2005), reprinted in 2005 U.S.C.C.A.N. 3, 5 ("[CAFA]
corrects a flaw in the current diversity jurisdiction statute (28 U.S.C. § 1332) that prevents most
interstate class actions from being adjudicated in federal courts.").
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essentially drawing the federalism boundaries related to nationwide
class actions that the Supreme Court had previously been unwilling
to dictate. The Class Action Fairness Act of 2005 sought this goal by
expanding the jurisdiction of federal courts to include class actions
where minimal, rather than complete, diversity was met and the total
potential amount at issue was over five million dollars. 22' Further,
the legislation also permitted removal without the consent of all
defendants, allowed defendant state residents to file for removal, and
eliminated the one-year time limit on seeking removal for class
actions.2 2 As stated in the Senate Judiciary Committee's report in
support of the bill, "Because interstate class actions typically involve
more people, more money, and more interstate commerce
ramifications than any other type of lawsuit, the Committee firmly
believes that such cases properly belong in federal court.
22
1
While addressing the federalism problem inherent within
nationwide class actions, this act was certainly not the kind of
legislation envisioned by Justice Ginsburg or the Ad Hoc Committee
on Asbestos Litigation as a real solution to the regulatory problems
created by such controversies.224 Indeed, CAFA placed greater
restrictions on potential settlements of class actions. 25 In so doing,
Congress underscored the decision in Amchem limiting courts'
regulatory role but provided no alternative means for resolving the
underlying issues. As such, Congress largely embraced policy goals
that effectively limit the ability of courts to protect consumer
interests through claim aggregation. Further, there are significant
questions as to whether CAFA actually provides an effective balance
to the federalism issues inherent within nationwide class actions.
221. See id. at 28 (detailing the CAFA's modifications to removal procedures and federal
jurisdiction over class actions). CAFA did create a "Home State" and a "Local Controversy"
exception to federal jurisdiction under the modified provisions of 28 U.S.C. § 1332, both of
which require that two-thirds of the plaintiff class reside in the same state. See id. at 28-29.
222. See id. at 29. However, the legislation did keep in place the requirement that removal
occur within thirty days of notice of grounds for removal. See id.
223. Id. at 5.
224. See Amchem Prods., Inc. v. Windsor, 521 U.S. 591, 598 (1997) (concluding that real
reform would require federal legislation creating a "national ... dispute-resolution scheme").
225. See S. REP. NO. 109-14, at 29-35 (2005), reprinted in 2005 U.S.C.C.A.N. 3, 28-34.
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A. The Policy Issues Underlying CAFA
Citing what the Senate report referred to as a problem of "state
court provincialism" in the area of nationwide class actions, the
stated purpose of CAFA was to correct "a technical glitch in the
diversity jurisdiction statute" that excluded many such cases from
federal courts. 26 But as the "complete diversity" requirement has
been imputed to federal diversity jurisdiction since 1806,227 it is
difficult to imagine how the Senate could have realistically
considered "complete diversity" to be a "glitch." Indeed, the
implication that CAFA amounted to mere procedural change has
been severely criticized by some commentators as anti-democratic in
masking the significant substantive effects of the legislation.228
Yet CAFA does largely resolve the federalism issue of
jurisdictional control over nationwide classes outlined earlier. 29
Aside from the rare cases of a "home state" or "local controversy"
exception,"3 defendants will now be able to successfully remove
most interstate class actions to federal court. Further, significant
issues involving the adequate representation of class members and
the "judicial blackmail" effect of class certification were presented in
support of CAFA.231
But these are problems that are inherent to the aggregation of
mass claims, not necessarily inherent to the protection of broad
consumer interests. Seen in the context of Justice Burger's earlier
point from Deposit Guaranty,3 ' Congress essentially combated the
untoward consequences of class aggregation by limiting the most
available form of consumer relief. The implication of Justice
Ginsburg's comments in Amchem about congressional inaction in
dealing with the national asbestos crisis is that such broad consumer
226. Id. at 6.
227. Strawbridge v. Curtiss, 7 U.S. (3 Cranch) 267 (1806).
228. See Lind, supra note 112 (arguing that the expansion of federal jurisdiction over class
actions combined with the heightened federal limitations on certification represents a denial of
substantive rights); Vairo, Judicial v. Congressional, supra note 59.
229. See S. REP. No. 109-14, at 10-14 (2005), reprinted in 2005 U.S.C.C.A.N. 3, 11-15.
230. See supra note 221 and accompanying text (outlining these exceptions).
231. See S. REP. NO. 109-14, at 14-22 (2005), reprinted in 2005 U.S.C.C.A.N. 3, 14-23.
232. Deposit Guar. Nat'l Bank v. Roper, 445 U.S. 326, 339 ("[T]he remedy for abuses does
not lie in denying the relief sought . . . but with re-examination of Rule 23 as to untoward
consequences.").
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product issues require legislative solutions.233 But rather than
provide any legislative solutions to the management of broad
consumer product issues, CAFA simply expanded Amchem's
limitations of judicial regulation. By moving these cases into federal
court under a broadened diversity jurisdiction, Congress reduced the
side effects of class certification by limiting the availability of the
remedy.
1. Drive-By Certification
Madison County, Illinois, a small rural county with a penchant
for certifying nationwide class actions, provided a perfect poster-
child for class action reformers supporting CAFA.234 Decisions by
Madison County judges to certify controversial nationwide classes235
allowed CAFA supporters to clearly define the menace of isolated
jurisdictions applying a "'I never met a class action I didn't like'
approach to class certification." '36 Indeed, the specter of backwater
judges adjudicating broad nationwide classes with effects on
interstate commerce illustrates the longstanding concern about bias
against out-of-state defendants that underlies the historical basis for
diversity jurisdiction.237
While some of this "drive-by certification" rhetoric may be
overblown,238 the imbalance in the standards applied to certifying
class actions does present a serious issue to both out-of-state
defendants and other states. The Senate report on CAFA noted that
state courts were dictating national policy by certifying actions that
233. Amchem Prods., Inc. v. Windsor 521 U.S. 591, 598-99 ("In the face of legislative
inaction, the federal courts-lacking authority to replace state tort systems with a national toxic
tort compensation regime-endeavored to work with the procedural tools available to improve
management of federal asbestos litigation.").
234. See S. REP. NO. 109-14, at 13, 22-23 (2005), reprinted in 2005 U.S.C.C.A.N. 3, 13-14;
see also AM. TORT REFORM ASS'N, JUDICIAL HELLHOLES 2004 (2004), http://www.atra.org/
reports/hellholes/2004/hellholes2004.pdf. Moreover, by 2007, the American Tort Reform
Association moved Madison County off its primary list of offenders, citing improvements in
judicial management in the county. See AM. TORT REFORM ASS'N, supra note 213.
235. See, e.g., Phillips v. Ford Motor Co., No. 99-L-1041, 2003 WL 23353492 (I11. Cir. 2003)
(certifying a nationwide class seeking recovery for paint defects in older model Ford vehicles).
But see Ford Motor Co. v. Sheldon, 113 S.W.3d 839 (Tex. App. 2003) (rejecting previously this
proposed class).
236. S. REP. No. 109-14, at 22 (2005), reprinted in 2005 U.S.C.C.A.N. 3, 22.
237. See id at 11-12, reprinted in 2005 U.S.C.C.A.N. 3, 12-13.
238. See id. at 22. It should be noted that several of the abusive certification decisions cited
in the Senate report were subsequently overturned on appeal.
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affected interstate commerce,"' even when the major parties
involved had no significant contact with the forum 4.2 " The report
argued that in so doing, state courts were usurping the regulatory
authority of state and federal officials.24' While the Supreme Court
allowed just this type of action in Shutts, the Court's rationale was
based upon the protection afforded by a conservative analysis of the
requirements of Rule 23.242 By broadening the diversity jurisdiction
of federal courts to include almost any class action with interstate
effects,243 CAFA allowed out-of-state defendants to remove such
actions to federal courts, ensuring that the more restrictive view of
courts' regulatory roles expressed in Amchem would be applied to
most nationwide class actions.
Through this jurisdictional change, CAFA's supporters hoped to
limit the blackmail effect felt largely by corporate defendants facing
class certification in state courts.2 " Citing Judge Posner's opinion
from Rhone-Poulenc,24 the Senate report argued that:
Because class actions are such a powerful tool, they can
give a class attorney unbounded leverage, particularly in
jurisdictions that are considered plaintiff-friendly. Such
leverage can essentially force corporate defendants to pay
ransom to class attorneys by settling-rather than litigating-
frivolous lawsuits. This is a particularly alarming abuse
because the class action device is intended to be a
procedural tool and not a mechanism that affects the
substantive outcome of a lawsuit. Nonetheless, state court
judges often are inclined to certify cases for class action
treatment not because they believe a class trial would be
more efficient than an individual trial, but because they
239. Id. at 23-27 ("Why should an Alabama state court tell 20 million people in all 50 states
what kind of airbags they can have in their cars?").
240. See id. at 13.
241. Id. at 24 (quoting District of Columbia Insurance Commissioner Lawrence Mirel as
testifying "class actions 'frequently go[] around or simply ignore[] the role of state regulators"'
(alterations in original)).
242. Phillips Petroleum Co. v. Shutts, 472 U.S. 797 (1985).
243. See S. REP. NO. 109-14, at 28-29 (2005), reprinted in 2005 U.S.C.C.A.N. 3, 28-29.
244. See id. at 20-21, reprinted in 2005 U.S.C.C.A.N. 3, 21.
245. Id. at 21, reprinted in 2005 U.S.C.C.A.N. 3, 21.
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believe class certification will simply induce the defendant
to settle the case without trial. 46
CAFA's drafters highlighted these policy fears in order to
support their effort to enforce the narrow, federal interpretation of
class certification's requirements under Rule 23, rather than the more
expansive use of class certification implemented by some state
courts. As such, the question that starts to emerge in response to the
passage above is whose substantive rights are affected by the
limitation of class certification?
2. The Consumer Class Action Bill of Rights
However, CAFA was also arguably intended as a defense of
absent plaintiff class members' interests against unscrupulous class
counsel. 47  The legislation created what its supporters called a
''consumer class action bill of rights," which enacted provisions
meant to limit abusive settlements that primarily benefit class
counsel 48 Focusing extensively on the use of coupon settlements in
negative-value class claims, the Senate report lists over twenty cases
where class members received negligible benefits while class counsel
received extensive fees.249 The examples range from unfavorable
coupon settlements-such as a class settlement with a manufacturer
of asbestos-laden crayons that provided class members a $0.75
246. Id. at 20-21, reprinted in 2005 U.S.C.C.A.N. 3, 21.
247. Id. at 14-21. Following CAFA, there have in fact been some high profile cases where
prominent class action plaintiff attorneys were charged with fraud in connection with their
handling of class action claims. See Michael Parrish, Leading Class-Action Lawyer Pleads Guilty
to Conspiracy, N.Y. TIMES, Oct. 30, 2007, at C9 (detailing the guilty plea of one of the country's
most prominent class action attorneys for conspiring to obstruct justice because of efforts made to
ensure his firm was named lead counsel); see also Adam Liptak, Fraud Inquiry Looks at Lawyers
in Diet-Drug Case, N.Y. TIMES, Mar. 24, 2007, at A I (detailing a federal grand jury investigation
of attorneys involved in the fen-phen settlement who allegedly defrauded their clients of portions
of their settlement payouts).
248. See S. REP. No. 109-14, at 5 (2005), reprinted in 2005 U.S.C.C.A.N. 3, 6 ("[Section 5 of
CAFA] includes a consumer class action bill of rights, with multiple components. One element
prohibits federal courts from approving coupon or 'net loss' settlements without making written
findings that such settlements benefit the class members. Another element specifies the methods
for calculating attorneys' fees in class settlements in which coupons constitute all or part of the
relief afforded to claimants to ensure that such fee awards are consistent with the benefits
afforded class members or the amount of real work that the class counsel have performed in
connection with the litigation. Yet another element of the bill of rights provides an additional
mechanism to safeguard plaintiff class members' rights by requiring that notice of class action
settlements be sent to appropriate state and federal officials, so that they may voice concerns if
they believe that the class action settlement is not in the best interest of their citizens.").
249. Id. at 14-20, reprinted in 2005 U.S.C.C.A.N. 3, 15-20.
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coupon towards the purchase of new crayons and class counsel over
$600,000 in fees 25 ---to even more extreme cases where class
members actually lost money as a result of the settlement 251 and even
would have been required to sell their homes if they had not opted
out.
25 2
In an effort to block such outcomes, CAFA established new
requirements for the approval of class settlements.253  First, CAFA
requires judicial findings of a proposed settlement's benefits to
consumers, specifically including an examination of the actual value
and expected utilization of coupons used as part of the settlement. 4
Second, CAFA establishes significant limitations on the methods
used for determining attorneys' fees in settlements, in an effort to
limit large payouts to class counsel when the class itself receives
little of value. 5' Finally, the legislation also created extensive
notification requirements, specifying state and federal authorities to
be made aware of class settlements in order to allow relevant
agencies time to object.256
B. CAFA's Shortcomings
Lost within these new requirements, however, is that class
claims often represent more to plaintiffs than just the financial
recovery sought, particularly for negative-value claims where
aggregation may provide the only significant form of consumer
protection for the product involved. Situations involving tainted dog
food or lead paint on toys may present significant health concerns
but no individual damages high enough to warrant a sole plaintiff to
sue. In such cases where there is no large, positive-value claim that
250. Id. at 18, reprinted in 2005 U.S.C.C.A.N. 3, 18.
251. Id. at 14-15, reprinted in 2005 U.S.C.C.A.N. 3, 15. One class settlement approved by an
Alabama state court involved the Bank of Boston where plaintiffs' counsel were paid $8.5 million
in fees that were simply deducted from class members' escrow accounts with the bank, often
significantly exceeding the $8.76 awarded to individual class members as part of the settlement.
See Kamilewicz v. Bank of Boston Corp., 92 F.3d 506 (7th Cir. 1996).
252. See S. REP. No. 109-14, at 15 (2005), reprinted in 2005 U.S.C.C.A.N. 3, 15-16 (citing a
class settlement approved in Kansas that would have required some of the class members to sell
their homes for twice their appraised value to the defendant); Kansas Case in Class by Itself,
NAT'L L.J., Mar. 15, 1999.
253. See S. REP. No. 109-14, at 29-35 (2005), reprinted in 2005 U.S.C.C.A.N. 3, 29-35.
254. Id.
255. Id.
256. Id.
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can move forward absent aggregation, denial of class certification
bars judicial influence over the underlying consumer protection
problem altogether.
Individual, negative-value plaintiffs are often not even interested
in the paltry relief they might individually receive." 7 What such
plaintiffs do care about is eliminating the underlying problem:
forcing companies to be more careful about hazardous products that
affect consumers. As such, negative-value plaintiffs may not care
about the coupon they are eligible to receive as a result of a class
action, but they do care about the consumer protection issue that
underlies the coupon.
Amid CAFA's focus on the regulatory effect of state court
decisions, the "blackmail effect" of class certification on corporate
defendants, and the protection of absent class members' interests,
there is one significant policy interest that is overlooked: the ability
of consumers to seek redress and protection through aggregation. As
the federal courts have taken a more restrictive view of class
certification requirements and Congress has extended the application
of this view by expanding federal jurisdiction over class actions, the
original goal behind the 1966 changes to Rule 23 has necessarily
been limited. As such, commentators have described CAFA as a
procedural effort at tort reform,25 rather than an attempt to protect
class members' true interests. Further, CAFA's expansion of federal
jurisdiction over interstate class actions through diversity, rather than
legislation creating federal question jurisdiction, provides only a
partial answer to the federalism issues inherent within nationwide
class actions. Accordingly, CAFA has changed the dynamic of the
policy debate associated with nationwide class actions without
providing any lasting solutions to the underlying issues involving
regulation or federalism.
257. See Christopher R. Leslie, The Significance of Silence: Collective Action Problems and
Class Action Settlements, 59 FLA. L. REv. 71, 120 (2007) (noting that participation rates in most
low-value settlements are less than 15 percent of the eligible class, particularly coupon
settlements where participation rates have been as low as 0.002 percent).
258. See, e.g., Lind, supra note 112, at 747; Michael P. Allen, A Survey and Some
Commentary on Federal "Tort Reform, " 39 AKRON L. REv. 909, 933 (2006).
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1. CAFA's Window Dressing
While CAFA was at least partially directed at these two issues,
the Senate report outlining its intent masks the fact that the end result
is to limit the use of class actions altogether,259 leaving one
commentator to describe the findings and purposes behind the statute
as at best "window dressing" and at worst "bullshit." 6 ' In attacking
CAFA as a covert effort to limit both plaintiffs' substantive rights
and states' policy decisions, Professor JoEllen Lind argues that
"CAFA is designed to make it much more difficult for products
liability actions and mass tort cases to be brought as class actions at
all, because the legislation specifically requires that the federal
standards for class certification-an increasingly demanding
requirement-be applied to them and the bill's drafters assume that
these actions will not be certified. '26 ' Further, some commentators
have suggested that CAFA was also intended to completely forestall
negative-value consumer claims. 62
Indeed, the bar on nationwide class actions presented by the
choice-of-law analysis in federal courts was at least partially
challenged during the course of the legislative debate regarding
CAFA.263 While not outlining federal choice-of-law standards for
such cases, Senator Dianne Feinstein suggested an amendment that
would have at least reminded federal courts that the relevance of
more than one state's law to an action should not prevent
certification due to choice-of-law conflicts where subclasses could be
effectively used.26 While this amendment presented a fairly tepid
response to the restrictive approach to Rule 23 taken in federal
courts, the Senate's rejection of even this limited language suggests
that CAFA's primary supporters were less interested in protecting
consumer interests than in limiting the dangers presented by class
certification to corporate defendants.
259. See S. REP. No. 109-14 (2005), reprinted in 2005 U.S.C.C.A.N. 3.
260. See Stephen B. Burbank, Aggregation on the Couch: The Strategic Uses of Ambiguity
and Hypocrisy, 106 COLUM. L. REV. 1924, 1942 (2006) (citing HARRY G. FRANKFURT, ON
BULLSHIT (2005)).
261. See Lind, supra note 112, at 747.
262. Id.
263. See S. Amendment 4 to S. 5, 109th Cong., 151 CONG. REC. S1215 (daily ed. Feb. 9,
2005) (proposing an amendment to CAFA that would have instructed federal courts not to deny
class certification just because "the law of more than one state will be applied").
264. Id.; see also Nagareda, supra note 216, at 1919.
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2. CAFA's Choice-of-Law Irony
Far from advancing any federal method for resolving the choice-
of-law conflict, CAFA expressly swears off any intent to alter the
complex application of state substantive law to nationwide class
actions under federal diversity jurisdiction.265  As detailed in the
Senate report, "[T]he Act does not change the application of the Erie
Doctrine, which requires federal courts to apply the substantive
[state] law dictated by applicable choice-of-law principles in actions
arising under diversity jurisdiction. ' 266 Since the application of state
law in nationwide class actions presents multiple problems for class
certification, the adoption of such language underlines the, at best,
ambivalent attitude of CAFA's supporters towards this restriction.
Yet for a statute that was largely supported by the premise that
class certification of nationwide actions presented threats to the
federal realm of interstate commerce, 67 the adherence to state
substantive law proves more than just ironic. As detailed by
Professor Richard A. Nagareda, Congress's decision to expand
federal diversity jurisdiction-rather than create federal question
jurisdiction through some sort of federal law regarding nationwide
consumer controversies-presents potential problems for the desired
application of class certification requirements in federal courts.268 As
held in Klaxon Co. v. Stentor Electric Manufacturing Co.,269 federal
courts must apply the choice-of-law provisions adopted by the state
in which the court sits. 7 Accordingly, a district court sitting in
Oklahoma would be ostensibly bound to adopt the Oklahoma
Supreme Court's decision to allow certification of a nationwide class
when the law of a defendant's home state can be applied to all of the
claims,271 even though this decision was directly criticized by the
265. S. REP. No. 109-14, at 49 (2005), reprinted in 2005 U.S.C.C.A.N. 3, 46 (citing Erie R.R.
v. Thompkins, 304 U.S. 64 (1938)); see also H.R. REP. No. 108-144, at 26 (2003) ("[CAFA] does
not change substantive law-it is, in effect, a procedural provision only. As such, class action
decisions rendered in Federal court should be the same as if they were decided in State court-
under the Erie doctrine, Federal courts must apply State substantive law in diversity cases.").
266. S. REP. No. 109-14, at 49 (2005), reprinted in 2005 U.S.C.C.A.N. 3, 46.
267. Id. at 5, reprinted in 2005 U.S.C.C.A.N. 3, 5 ("Because interstate class actions typically
involve more people, more money, and more interstate commerce ramifications than any other
type of lawsuit, the Committee firmly believes that such cases properly belong in federal court.").
268. See Nagareda, supra note 216, at 1912-22.
269. 313 U.S. 487 (1941).
270. Id. at 496.
271. Ysbrand v. DaimlerChrysler Corp., 2003 OK 17, 81 P.3d 618.
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Senate report supporting CAFA. 7 2 In such cases, CAFA does not
fully prevent the application of class certification standards from
individual states that are not in line with federal precedent. As such,
the forum shopping concerns underlying both Eriei3 and CAFA
could return if more state supreme courts begin to diverge in their
policy assessments of class certification. 74
However, the fact that CAFA will push most nationwide class
actions into federal court-leaving little opportunity for state courts
to make such assessments-makes this possibility very unlikely.
Accordingly, CAFA has been criticized as an undemocratic attack on
the independence of states to apply their own policy judgments to the
adjudication of nationwide class actions.275 Yet it is very difficult to
argue that Congress overstepped its constitutional authority by using
a procedural device to limit the aggregation of mass claims or the
ability of states to regulate such controversies. 276  The power of
Congress to establish federal court jurisdiction is well established,277
and the potential effects of nationwide class actions clearly present
issues of national concern regarding the regulation of interstate
commerce.
Through its jurisdictional expansion of the restrictive
interpretation of Rule 23 prevalent in federal courts, Congress has
essentially removed a significant layer of potential national
regulation. But in the balance of federalism concerns presented by
interstate commerce regulation, Congress's ability to limit the
protection of certain rights is just as valid as Congress's ability to
grant those rights.278 While supporting this decision on the basis of
272. See S. REP. No. 109-14, at 25 (2005), reprinted in 2005 U.S.C.C.A.N. 3, 25.
273. Erie R.R. v. Tompkins, 304 U.S. 64 (1938).
274. There is some indication, however, that states have begun to react to the same corporate
lobbying that drove CAFA by creating more restrictive procedures for handling state class
actions. See Feit, supra note 73, at 927.
275. See Vairo, Judicial v. Congressional, supra note 59, at 1621; Lind, supra note 112, at
776-77.
276. But see Vairo, Judicial v. Congressional, supra note 59, at 1616-25 (arguing that CAFA
could be viewed as unconstitutional under the analysis developed in the Supreme Court's recent
federalism cases).
277. See, e.g., U.S. CONST. art. III; Ex parte McCardle, 74 U.S. (7 Wall.) 506 (1868); Sheldon
v. Sill, 49 U.S. (8 How.) 441 (1850).
278. If seen as de facto regulatory action, as both CAFA and commentators have suggested,
the actions of state courts that burden interstate commerce could also be seen to raise issues
related to the dormant commerce clause. See Quill Corp. v. North Dakota, 504 U.S. 298, 312
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the dangerous effects inherent in class actions, CAFA provides less
of a remedy to the underlying regulatory problems in order to
prevent one remedy's side effects. As such, the compelling issue
underlying the future consequences of CAFA is not what effects the
act will have on the balance of federalism but what future protections
will be provided to nationwide claimants whose interests can no
longer be protected via the judicial regulation inherent to claim
aggregation.
V. GETTING WHAT YOU PAID FOR
"Respect us, that's the message." '279 This was the sentiment of
one of the jurors from the first Vioxx trial after assessing $229
million in punitive damages against Merck. 2" As the forewoman of
the jury said, "We expect accountability; we expect them to be open
with us; we expect them to be honest with us. ' 281 However, "us" and
"them" really have no boundaries in the broader scope of our
consumer-based economy. The executives at Merck surely buy toys
for their children and dog food for their pets just like everyone else
in this country, and when they do so, their expectations are likely
very similar to the ones of that Texas jury.
But are these expectations realistic? In the present balance of
consumer protections, are manufacturers really compelled to be
accountable for the products they offer to U.S. consumers, to be open
with consumers about the hazards that may accompany these
products, and to be honest with consumers about these dangers? The
current state of consumer litigation does not suggest this to be the
case. Lost in the valid criticism of many class actions as simple
transfers of "money from corporations to class counsel ' 282 are the
abuses of consumer trust that underlie these suits. Further, the
current state of U.S. regulatory agencies should provide no one with
the confidence that these protections are being provided by the
(1992) (outlining the development of the dormant commerce clause's limitation on state influence
over interstate commerce).
279. Berenson, Merck Liable, supra note 26, at Al.
280. Id. This sentiment was clearly not shared by Texas appellate courts as this judgment was
first reduced and subsequently thrown out altogether. See Alex Berenson, Courts Reject Two
Major Vioxx Verdicts, N.Y. Times, May 30, 2008, at C2.
281. Id.atCl3.
282. S. REP. No. 109-14, at 4 (2005), reprinted in 2005 U.S.C.C.A.N. 3, 6.
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federal government.283 So, what's going to change: the direction of
class action litigation, federal regulatory policy, or consumer
expectations?
A. Litigation's Consumer Protection Limitations
Despite the many legitimate criticisms of CAFA,8 4 the problems
that prompted the legislation-isolated state courts applying uneven
certification standards with interstate commerce effects, absent class
members being used by self-interested class counsel, and corporate
defendants being manipulated by the financial pressures of large
class actions-cannot be disregarded. Indeed, these problems go to
the very heart of the Supreme Court's fears about misuse of the class
action mechanism.285 As outlined in Part II, however, these issues
are inherent in class action litigation. The size of the class provides
both its power and its potential for abuse. So too, the widespread
effects of such litigation naturally create tension points for both
horizontal and vertical federalism. Accordingly, the limitation of
potential abuses, as attempted in CAFA, necessarily results in a
decrease in the potential benefits of class actions, namely the
protection of broad consumer interests.
To ignore that CAFA was directly intended to weaken the
viability of consumer class actions, however, would be to hide from
the political realities that fueled the legislation."t 6 Having spent
283. See William Neikirk, Anger, Indignation Mark Toy Recall Hearing, CHI. TRIB., Sept. 20,
2007, at 4. Discussing the wave of recent recalls involving children's toys with lead paint,
"CPSC Commissioner Thomas Moore said, 'We are all to blame,' including 'those who stood by
and quietly acquiesced while the commission was being reduced to a weakened regulator."' Id.
284. See, e.g., Burbank, supra note 260, at 1942 (questioning the true motives of CAFA's
drafters); Lind, supra note 112 (arguing that CAFA's expansion of federal jurisdiction over class
actions combined with the heightened federal limitations on certification represents a denial of
substantive rights); Nagareda, supra note 216, at 1912-22 (arguing that CAFA cannot actually
adhere to the Erie Doctrine while limiting states' abilities to set their own standards for class
certification); Vairo, Judicial v. Congressional, supra note 59, at 1616-25 (arguing that CAFA
could be viewed as unconstitutional under the analysis developed in the Supreme Court's recent
federalism cases).
285. See Deposit Guar. Nat'l Bank v. Roper, 445 U.S. 326, 339 (1980) ("That there is a
potential for misuse of the class-action mechanism is obvious. Its benefits to class members are
often nominal and symbolic, with persons other than class members becoming the chief
beneficiaries.").
286. See Samuel Issacharoff, Settled Expectations in a World of Unsettled Law: Choice of
Law After the Class Action Fairness Act, 106 COLUM. L. REv. 1839, 1862 (2006) ("CAFA clearly
sought to keep in place the inherited choice of law regime, under the assumption that the spiral of
choice of law dictates of the multiple states where the claims accrue would effectively bar
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millions of dollars lobbying for the corporate protections provided by
CAFA, business groups "got what they paid for"' as one editorial
proclaimed, namely, a decrease in the litigation and regulatory
pressures created by aggregated claims.118  While well-supported
positive-value claims will move forward regardless of aggregation,
the ultimate settlement of the broad consumer controversies
underlying such claims is certainly impacted by the current restraints
on class certification. Further, legitimate negative-value claims that
may achieve class certification will be far less appealing to plaintiffs'
counsel under the fee restrictions implemented by CAFA.289
Negative-value claims that are settled under these circumstances may
also not provide sufficient pressure on manufacturers to adequately
address the underlying problems.
Since CAFA is not retroactive, the legislation's broadened
jurisdictional standards do not apply to the Vioxx class actions,
which were generally all filed before the legislation's approval. 9
But the pending Vioxx settlement does highlight some of the issues
raised above and provides insight into what the future results of
driving similar mass consumer claims into federal courts will be.
With plaintiffs unable to certify a nationwide class,29" ' Merck was
able to separately litigate the multitude of causation factors
associated with individual patients,292 allowing them to undercut the
strength of plaintiffs' cases, which was Merck's prior knowledge of
nationwide class actions."); Editorial, The Class Action Unfairness Act, N.Y. TIMES, Apr. 25,
2003, at A30.
287. Editorial, A Dismal Class-Action Finale, N.Y. TIMES, Feb. 12, 2005, at A16.
288. Some companies have also attempted to prevent the aggregation of consumer claims
through arbitration clauses in sales contracts that contractually bar the aggregation of claims. See
Nagareda, supra note 216.
289. See S. REP. No. 109-14, at 29-35 (2005), reprinted in 2005 U.S.C.C.A.N. 3, 29-35.
Because CAFA sets general requirements linking settlement participation and coupon utilization
rates with the fees paid to plaintiffs' counsel, plaintiff attorneys are going to be far less willing to
embrace the litigation risks associated with claims where such rates are historically low. See
Leslie, supra note 257 and accompanying text.
290. See Pritchett v. Office Depot, Inc., 420 F.3d 1090, 1096 (10th Cir. 2005). Pritchett held
that CAFA was not retroactive and pointed to the floor statement of Congressman Bob Goodlatte:
"Since the legislation is not retroactive, it would have absolutely no effect on the 75 class actions
already filed against Merck in the wake of the Vioxx withdrawal." Id.
291. See In re Vioxx Prods. Liab. Litig., 239 F.R.D. 450 (E.D. La. 2006) (denying
certification to a nationwide class of plaintiffs claiming personal injury as a result of taking
vioxx).
292. See Alex Berenson, Plaintiffs Find Payday Elusive in Vioxx Cases, N.Y. TIMES, Aug. 21,
2007, at A l (detailing the success of Merck's litigation strategy) [hereinafter Berenson, Payday].
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Vioxx's risks.293 Merck's strategy of attacking each case separately
produced a string of victories, and the few substantial judgments
against the company were always appealed and sometimes
automatically reduced, diminishing their impact through delay and
punitive damage caps.294  After years of appeals, almost no
significant plaintiff awards still stand,295 despite the disturbing
evidence of Merck's prior knowledge of the Vioxx's risks.296 While
likely forced to agree to a settlement simply because of the volume
of cases,297 Merck was still able to leverage a favorable agreement
based on the success of their strategy.298
Depending on how many settlement claims are eventually filed
from plaintiffs already involved in the roughly 25,000 current suits,
each claimant will receive roughly $120,000 minus legal fees.299
While the settlement will only be triggered if 85 percent of plaintiffs
agree to its terms,00 Merck's total liability under the agreement will
be capped at $4.85 billion, roughly nine months of the company's
profits.3"' The most controversial aspect of the agreement is that
plaintiffs' attorneys who wish to take part in the settlement are
required to recommend the settlement to all of their clients and
terminate representation of clients who choose to continue
litigation.3 2
Assuming that this settlement goes forward, have any of the
issues raised by both Congress and the courts as major problems in
the area of mass consumer claims been well served by handling these
cases individually rather than as a class? The courts did avoid
293. See Berenson et al., supra note 19 (detailing Merck's knowledge of Vioxx's risks).
294. See Berenson, Payday, supra note 292.
295. See Berenson, Courts Reject Two Major Vioxx Verdicts, supra note 280.
296. See Berenson et al., supra note 19 (detailing Merck's knowledge of Vioxx's risks).
297. See id. (noting that the judges handling the thousands of Vioxx cases against Merck were
likely tiring of the company's refusal to settle); Nocera, supra note 35 ("If Merck had continued
to fight, the judges could have piled on so many trials that the company would have been begging
for mercy.").
298. See Berenson, Analysts, supra note 27.
299. Id.
300. As of March 2008, more than 44,000 plaintiffs had agreed to join the settlement,
signaling that the agreement's threshold numbers will be met if most of these submission are
verified. See Vioxx Settlement on Track as 44,000 Sign Up, N.Y. TiMES, March 4, 2008, at C 11.
301. Id.
302. See Berenson, Alteration, supra note 126 (detailing attempts by some plaintiffs'
attorneys to change these requirements arguing that they violate the attorneys' ethical obligations
to their individual clients).
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wading into unwieldy regulatory issues that would have
accompanied class certification," 3 but Merck was still likely forced
into a global settlement based solely on the volume of the cases."
Further, the real winner in the settlement is still plaintiffs' counsel, as
a relatively small number of firms will split nearly $2 billion in fees,
while the individual clients-many of whom have lost loved ones-
will collect less than $100,000 each after paying their attorneys.3 5
Concerns over unscrupulous plaintiffs' counsel should actually
be heightened in the wake of the settlement's provisions. The
requirement that counsel must recommend settlement to all of their
clients and withdraw from representing clients who do not choose to
settle raises fairly obvious ethical concerns about the duty of
plaintiffs' counsel to provide the best legal advice for their individual
clients.30 6 Yet unlike in a Rule 23 settlement, there is no requirement
that a court evaluate the fairness of the agreement, regardless of
whether it is unduly coercive on plaintiffs. Further, Merck's intent in
demanding this provision was to prevent plaintiffs' counsel from
cherry-picking the most meritorious claims for continued litigation,
while settling the difficult claims.30 7 In essence, Merck is trying to
limit plaintiffs' options in the same way they would be limited as
part of a class, without subjecting the company to the litigation
pressures and oversight inherent to class actions.
While Merck's success in the individual cases produced an
agreement that will keep the company out of bankruptcy,3 8 the
broader question is whether this result is really good for consumers.
Lost in the settlement's payout numbers and the effects on Merck's
stock price are the estimates of the number of people who died from
taking a pain reliever whose primary selling point was that it caused
303. See In re Vioxx Prods. Liab. Litig., 239 F.R.D. 450 (E.D. La 2006) (denying
certification to a nationwide class of plaintiffs claiming personal injury as a result of taking
Vioxx); Int'l Union of Operating Eng'rs Local No. 68 Welfare Fund v. Merck & Co., Inc., 192
N.J. 372 (2007) (denying certification to a nationwide class of third-party payors who helped pay
for Vioxx prescriptions as part of health insurance benefits).
304. See Berensen, Payday, supra note 287.
305. See Berenson, Analysts, supra note 27.
306. See Berenson, Alteration, supra note 126.
307. See id. Some commentators have suggested that plaintiffs' counsel will still manage to
separate out and litigate their strongest cases by using affiliate firms. See Daniel Fisher, Will the
Vioxx Settlement Work?, FORBES.COM, Nov. 13, 2007, http://www.forbes.com/2007/
11/12/merck-vioxx-lawsuits-biz-health-cz df 1112vioxx.html.
308. See Berenson, Analysts, supra note 27.
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less stomach irritation than other pain relievers3 9 -not a special life-
saving treatment but a pain reliever that Merck knew had serious
potential risks years before its recall."' Epidemiologists estimate
that Vioxx may have caused over 100,000 heart attacks, 1' with the
FDA estimating as many as 55,000 patient deaths.312 Identifying
which patients out of the twenty million people who took Vioxx had
heart attacks because of the drug and not other factors is obviously a
messy causation analysis, but the big picture numbers do not really
change as a result of twenty jury verdicts.
"I think they've gotten off quite easily, frankly, for the problems
that they've engendered," said Dr. Eric Topol, a cardiologist who co-
authored a study in 2001 warning of Vioxx's risks.3"3 Discussing the
larger impact of the settlement, Professor Richard Nagareda
commented, "It says to companies in the pharmaceutical industry and
other areas of mass tort litigation that it really is worth your time of
going through two or three or more years of cases." '314 The effect is
that the regulatory impact of mass consumer claims is watered down
over years of quarterly earnings expectations. The once immediate
threat to consumer safety becomes lost on the market amid a series of
individualized causation analyses.
What have often been ignored in the debates over CAFA are the
consequences of limiting the regulatory deterrence of consumer class
actions on the marketplace.3"5 In an economic system that generally
espouses minimal regulation, civil litigation is relied upon not only
to remedy individual rights but also to regulate the market itself.316
Unlike Europe, the U.S. does not require any pre-market testing for
309. See Lawyers Argue Merck Concealed Vioxx Risk, N.Y. TIMES, Mar. 7, 2006, at C4
("[Merck] sold the drug beginning in 1999 as a pain reliever for arthritis and osteoarthritis
sufferers who found other pain drugs too harsh on the stomach.").
310. See Berenson et al., supra note 19.
311. See Alex Berenson, Vioxx Jury Adds More in Damages, N.Y. TIMES, Apr. 12, 2006, at
Cl.
312. See Harris, supra note 1.
313. See Berenson, Analysts, supra note 27.
314. Carrie Johnson, Merck Agrees to Blanket Settlement on Vioxx, WASH. POST, Nov. 10,
2007, at D1.
315. See Elizabeth Chamblee Burch, CAFA's Impact on Litigation as a Public Good, 29
CARDOZO L. REV. (forthcoming Apr. 2008) (manuscript at 36), available at http://papers.
ssrn.com/sol3/papers/cfm?abstractid=100521 ("Perhaps the most important effect from a
consequentialist standpoint is that CAFA may weaken deterrence and inhibit litigation's use as ex
post regulation.").
316. See id.; Burbank, supra note 12, at 387.
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small consumer goods such as children's toys.317 As such, U.S.
policy on consumer safety is unique in that it places few barriers to
entering the market but instead relies upon the threat of post-market
litigation to regulate the actions of manufacturers.318  CAFA
identified serious problems that are inherent to class action litigation,
but in limiting the viability of consumer claims, CAFA undercuts the
ability of courts to serve this regulatory function.319 Maybe litigation
was never a stable way to balance the regulatory spectrum, but the
current trends in complex litigation leave U.S. consumers far more
dependent upon the regulatory capacity of government agencies.
B. The Caveat Emptor Commission32°
CAFA was adopted at the same time that the Bush
administration was "hollowing out" the very agencies tasked with
protecting consumer safety.32' While charged with regulating the
safety of products as diverse as toys and televisions, the budget for
the Consumer Product Safety Commission has been steadily cut,
reducing staff levels from nearly 1,000 employees in the 1970s to
just 420 employees today.3 22 As such, the C.P.S.C. has been forced
to limit its focus and currently investigates only 10 to 15 percent of
the reported injuries linked to consumer goods.323 Indeed, the
equipment used to test the flammability of clothing has not been
updated in three decades, and the area used to test whether toys will
easily break into small pieces that could be swallowed is simply the
spare space behind an office door. Discussing the cramped and
outdated facilities, the single employee assigned to testing toys
ironically noted, "This is the toy lab for all of America-for all of the
United States government!
3 24
317. See Lipton & Story, supra note 5, at CI.
318. See ROBERT A. KAGAN, ADVERSARIAL LEGALISM: THE AMERICAN WAY OF LIFE 4
(2003); Burch, supra note 307.
319. Elizabeth Chamblee Burch named this issue "CAFA's dirty little secret." See Burch,
supra note 307.
320. See Editorial, The Caveat Emptor Commission, N.Y. TIMES, Oct. 10, 2007, at A22.
321. See id.
322. See Eric Lipton, Safety Agency Faces Scrutiny Amid Changes, N.Y. TIMES, Sept. 2,
2007, at A 11.
323. Id.
324. Id.
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With only eighty-one field inspectors nationally, the C.P.S.C.
has even less ability to detect the importation of dangerous
products.325 For instance, the roughly fifteen million shipping
containers that entered the country through Los Angeles area ports
last year were overseen by a single inspector working just two to
three days a week. According to one report, customs agents in a
New York harbor had not seen a commission inspector in six
months. Yet even when inspectors identify potentially dangerous
items, they rarely have the authority to seize non-compliant products,
since many of the commission's standards are now voluntary.326 The
shift towards voluntary compliance standards formed a significant
portion of the Bush administration's deregulatory agenda,327 as many
of the top-level positions within the commission were filled with
former,industry executives.328
The concept of "voluntary compliance," however, does not seem
to translate well in the current global economy. When discussing
Chinese manufacturers, one former senior commission aide said,
"Time and again, through the translators, they made clear they did
not understand this concept .... What they told us was, 'As far as
we are concerned, voluntary means we don't have to."' 329 Further, as
the commission's ability to inspect imported products has decreased,
the amount of consumer products imported into the U.S. has
increased exponentially, with Chinese-made items alone accounting
for roughly twenty percent of all available consumer products for
sale in the country today.3  Overall, the C.P.S.C. appears ill-
equipped both practically and philosophically to meet the current
challenge of protecting U.S. consumers. The assessment of the
325. Id.
326. Id.
327. Id. The Commission also significantly narrowed the circumstances under which
companies must report safety defects, no longer requiring companies to report safety issues that
the company believed were predictable or involved misuse.
328. Id. For example, John Gibson Mullan, a former lawyer for the A.T.V. industry, became
the Commission's director of compliance, taking active involvement in discussions regarding
potential regulation affecting his prior clients. In describing Mullan's involvement to block a
proposed ban on the sale of adult-sized A.T.V's to children under sixteen, one former
Commission official involved with the debate said, "It was almost like he still worked for them,
not us." Id.
329. Id.
330. Id.
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commission's former poison prevention expert was simply: "Buyer
beware-that is all I have to say. '"331
The situation at the FDA, the agency charged with overseeing
the safety of medications and much of the nation's food supply, is
sadly similar. Expressing frustration with their lack of authority to
mandate warning labels on prescription medication, FDA officials
explained that they have no ability to track common dangers found to
be connected with a drug after it has been approved for the market.332
Further, serious questions have been raised about the financial ties of
FDA decision makers to the pharmaceutical industry.333 One drug
safety reviewer with over twenty years of experience at the FDA
testified before Congress that the agency had become apt to submit
to the demands of drug manufacturers, saying that regulators were
"'virtually incapable of protecting America' from unsafe drugs. 334
Amid budget cuts and closed inspection laboratories, the agency also
has little ability to adequately screen for dangerous food being
imported into the country.
C. Consumer Expectations
While perhaps unrealistic, U.S. consumer expectations are
certainly not far off from those of the mother of the child sickened
from contaminated spinach: "There is an assumption that everything
is going to be O.K., that someone must have checked this out...."'
Whose responsibility should it be to reconcile these expectations
with reality? As this mother realized, the FDA and C.P.S.C. are
clearly not doing much checking, often relying instead on voluntary
compliance. Merck seems to do some checking but clearly has its
331. Id. Suzanne Barone, the C.P.S.C.'s former head of the poison prevention unit, resigned
in 2005 after efforts to require inexpensive child-resistant caps on hair care products that had
burned toddlers were delayed so industry costs could be weighed against the potential benefit to
children. Id.
332. See Harris, supra note 1.
333. See Gardiner Harris & Alex Berenson, 10 Voters on Panel Backing Pain Pills Had
Industry Ties, N.Y. TIMES, Feb. 25, 2005, at Al.
334. See Gardiner Harris, F.D.A. Failing in Drug Safety, Official Asserts, N.Y. TIMES, Nov.
19, 2004, at A l (internal quotation marks omitted).
335. See Marian Burros, F.D.A. Inspections Lax, Congress is Told, N.Y. TIMES, July 18,
2007, at C3 (noting that since 2003 the number of food inspectors at the agency has decreased
while food imports have doubled).
336. Burros, supra note 6; see also supra text accompanying note 6.
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own agenda in determining what consumers need to know. 3 37  Toys
'R' Us says it is going to start checking.338 China says it has always
had a policy of checking.339
After surveying the many challenges facing courts in trying to
manage broad consumer product claims, it is simply not reasonable
to expect courts to be able to effectively enforce this multitude of
promises to U.S. consumers. As detailed in Amchem and CAFA, the
breadth of such consumer controversies threatens to distort the
judicial role into one of regulator rather than adjudicator. Consumer
product controversies that affect millions of consumers represent a
failure of government regulation, not a viable opportunity for judicial
action to balance the scales. Yet without realistic regulatory
safeguards, consumers are left with no other venue to seek
protection. The results have left the Supreme Court and Congress
struggling with answers that have so far failed to address the
underlying problems.
Combined with the limitation of courts' ability to manage broad
consumer issues, the Bush administration's drive towards
deregulation has left U.S. consumers with very few protections. But
in response to the recent wave of consumer product controversies,
legislators have begun to recognize the need for the FDA and
C.P.S.C. to play larger regulatory roles.34° Indeed, much like how the
corporate scandals of 2002 led to a significantly increased
enforcement role for the Securities and Exchange Commission,34' the
current wave of recalls could lead to a much broader agenda for
federal regulatory agencies overseeing consumer goods.
337. See Berenson et al., supra note 19; Vioxx Troubled Merck Scientist, supra note 14.
338. See Louise Story, A Boon for Lead-Testing Companies, N.Y. TIMES, Sept. 29, 2007, at
Cl ("Mattel, Walt Disney, Toys 'R' Us and scores of other toy makers and retailers are
responding to the series of recalls this year by adding new product testing in factories and on
store shelves.").
339. See Lipton, supra note 8, at C2 (In a hearing on the C.P.S.C.'s recent efforts, Senator
Richard Durbin "mocked a new agreement with Chinese officials to block lead in toys, saying
that the Chinese government told his office the policy had long been in place").
340. See id.; Harris, supra note 1. This push for broadened regulatory powers for the
agencies is not without its critics, including some at the agencies themselves. See Labaton, supra
note 9 (noting letters from the acting head of the C.P.S.C. stating opposition to proposed
legislation that would grant the agency greater powers).
341. See S.E.C. Charges Accountants and Firms with Sarbanes-Oxley Violations, N.Y.
TIMEs, Sep. 14, 2007 (discussing the broader enforcement powers granted to the S.E.C. through
the Sarbanes-Oxley Act of 2002 partially as a result of corporate scandals including Enron and
Tyco).
1093
LOYOLA OF LOS ANGELES LAWREVIEW [Vol. 41:1039
Without broader federal regulatory authority and funding, courts
will continue to be placed in the position of determining regulatory
policy through litigation. Further, state agencies and attorneys
general may begin to act independently, as with the recent suit
brought by California Attorney General Jerry Brown against toy
manufacturers for their use of lead paints. 42 Such independent state
action will ultimately raise federalism tensions and could raise
significant dormant commerce clause issues.
In the face of a changing global economy and pressing concerns
over consumer safety, however, some U.S. businesses have begun to
embrace the idea that federal regulation could provide valuable
protections for both companies and consumers.343 "'There seems to
be, at the moment, a fair amount of efforts under way by individual
industries to put into statute what had either previously been
voluntary consensus standards or industry goals,' said Rosario
Palmieri, a regulatory lobbyist at the National Association of
Manufacturers." '344 Mandatory federal safety regulations could help
U.S. companies compete against foreign manufacturers who have
previously chosen to ignore voluntary standards in favor of cost
savings. Further, such standards could help to restore consumer
confidence in the marketplace. But the ultimate issue is whether
such a sea change could serve to protect consumers. "What we need
to watch closely is if this will achieve a real increase in standards and
public protections or simply serve corporate interests," said Rick
Melberth, director of regulatory policy at OMB Watch, a
Washington group that tracks federal regulatory actions.345
As part of a long-term rebalancing of consumer protections,
federal regulation could be used to limit the litigation pressures faced
by companies willing to fully comply with federal standards.34
Indeed, the Supreme Court recently interpreted a preemption clause
included by Congress in the Medical Device Amendments of 1976 to
bar state common law claims against a certain class of medical
342. See Marc Lifsher & Abigail Goldman, Lead in Toys Sparks Lawsuit, L.A. TIMES, Nov.
19, 2007, at 1.
343. See Eric Lipton & Gardiner Harris, In Turnaround, Industries Seek US. Regulations,
N.Y. TIMES, Sept. 15, 2007, at 11 (noting, however, that this push is partially motivated by a
desire to establish low regulatory standards in advance of a possible Democratic administration).
344. Id.
345. Id.
346. See id.
1094
Spring 2008] CONSUMER PRODUCT PAIN RELIEF
devices that receive pre-market approval by the FDA.347 Merck, in
fact, unsuccessfully tried a similar argument before a district court
that FDA approval of the labeling for Vioxx should protect the
company from claims that the warnings were inadequate.348 The
Supreme Court will soon hear essentially the same argument in
Levine v. Wyeth,349 where both the drug company and the Bush
administration will argue that FDA approval of medical warnings
should impliedly preempt state law claims over their inadequacy.35 °
This case could potentially grant the FDA a vast expansion of
regulatory authority to preempt state law claims,35" ' just as consumer
confidence in the competence of federal regulatory agencies has
plummeted.
While such litigation protections may ultimately be necessary to
take courts out of an uneasy regulatory role, this shift absolutely
requires independent and effective regulatory agencies in order to
provide sufficient protection for consumers. Unfortunately, the
current state of disarray within U.S. regulatory agencies does not
support the grant of such preemption measures. If paired with
meaningful federal regulation and enforcement of consumer
protection standards, such corporate protections could ultimately
provide a more beneficial compromise with consumer interests than
our current reliance on the limited back-stop of complex litigation.
In such a far-off scenario, courts hopefully could focus on outlier
acts of individualized misconduct and leave the balancing of
regulatory policies to the agencies that are supposedly tasked to serve
this role. If the Supreme Court prematurely forces this shift by
347. Riegel v. Medtronic, Inc., 128 S. Ct. 999 (2008). Ironically, Justice Ginsburg, the author
of the Amchem majority opinion that checked many consumer product claims by limiting
aggregation, 521 U.S. 591 (1997), dissented in Riegel, arguing that interpreting the pre-emption
clause at issue to bar state liability claims conflicted with Congress's intent at the time to
strengthen consumer protections. 128 S. Ct. at 1012-20 ("It is 'difficult to believe that Congress
would, without comment, remove all means of judicial recourse' for large numbers of consumers
injured by defective medical devices." (quoting Silkwood v. Kerr-McGee Corp., 464 U.S. 238,
251 (1984))).
348. See Judge Rejects Merck's View on F.D.A. Issue, N.Y. TIMES, July 4, 2007, at C2.
349. 944 A.2d 179 (Vt. 2006), cert. granted, 128 S. Ct. 1118 (2008).
350. See Linda Greenhouse, Justices to Hear Cases on Product Liability, N.Y. TIMES,
January 19, 2008, at A21.
351. See Christen Linke Young, Agency Preemption Inputs in Riegel v. Medtronic, 118 YALE
L.J. POCKET PART 22 (2008) (arguing that the Court is unlikely to grant such broad power to the
FDA based on dicta in Riegel).
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granting broad preemptive power to FDA decisions, however, the
ultimate effects for consumers could prove disastrous.
